<SEC-DOCUMENT>0001493152-22-009477.txt : 20220408
<SEC-HEADER>0001493152-22-009477.hdr.sgml : 20220408
<ACCEPTANCE-DATETIME>20220408161559
ACCESSION NUMBER:		0001493152-22-009477
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220404
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220408
DATE AS OF CHANGE:		20220408

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		22817176

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:SMTI="http://sanaramedtech.com/20220404">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_SMTI_sanaramedtech.com_20220404 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20220404_20220404 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityCentralIndexKey">0000714256</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20220404.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-04-04to2022-04-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-04</xbrli:startDate>
        <xbrli:endDate>2022-04-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90E_edei--DocumentType_c20220404__20220404_zOPQ1h2ZJrZ"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span id="xdx_908_edei--DocumentPeriodEndDate_c20220404__20220404_zGx6r8fDcv6l"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 4, 2022</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_908_edei--EntityRegistrantName_c20220404__20220404_zEYQUEWG6wwb"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityRegistrantName">SANARA
    MEDTECH INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
    name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20220404__20220404_zAyWpMrYZzza"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20220404__20220404_zNhSHKjhcQCk"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityFileNumber">001-39678</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityTaxIdentificationNumber_c20220404__20220404_zPmayXTNh0fa"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityTaxIdentificationNumber">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20220404__20220404_zhvw6w9g6Bx3"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityAddressAddressLine1">1200
    Summit Avenue</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressAddressLine2_c20220404__20220404_zQaTQLSIw6Z6"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityAddressAddressLine2">Suite 414</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20220404__20220404_zscG7qpRzouf"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityAddressCityOrTown">Fort
    Worth</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20220404__20220404_z6RZcCJ9jST1"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20220404__20220404_zgAuo8VwxHn5"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:EntityAddressPostalZipCode">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_90A_edei--CityAreaCode_c20220404__20220404_zlG8NwDvBQVd"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:CityAreaCode">(817)</ix:nonNumeric></span> <span id="xdx_908_edei--LocalPhoneNumber_c20220404__20220404_zAFRMEEvevlk"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:LocalPhoneNumber">529-2300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--WrittenCommunications_c20220404__20220404_zIj7VztRVbg7"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--SolicitingMaterial_c20220404__20220404_zUzUVkKm8Wk4"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--PreCommencementTenderOffer_c20220404__20220404_zRWGqlYXWybh"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20220404__20220404_zu9MBb37uQw9"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20220404__20220404_zfAay4VdsDs7"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:Security12bTitle">Common
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20220404__20220404_zmtLhOmWV6N1"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" name="dei:TradingSymbol">SMTI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_90A_edei--SecurityExchangeName_c20220404__20220404_zcJgmh6oCQz4"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20220404__20220404_zpZEOCZvMJvi"><ix:nonNumeric contextRef="From2022-04-04to2022-04-04" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01 Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Closing
of Merger</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously announced, on April 1, 2022, Sanara MedTech Inc., a Texas corporation (the &#8220;Company&#8221;), entered into an Agreement
and Plan of Merger (the &#8220;Merger Agreement&#8221;), by and among the Company, United Wound and Skin Solutions, LLC, a Delaware limited
liability company and wholly owned subsidiary of the Company (&#8220;UWSS&#8221;), Precision Healing Inc., a Delaware corporation (&#8220;Precision
Healing&#8221;), PH Merger Sub I, Inc., a Delaware corporation (&#8220;Merger Sub I&#8221;), PH Merger Sub II, LLC, a Delaware limited
liability company (&#8220;Merger Sub II&#8221;), and Furneaux Capital Holdco, LLC (d/b/a BlueIO), solely in its capacity as the representative
of the securityholders of Precision Healing (&#8220;BlueIO&#8221; and together with the other parties to the Merger Agreement, the &#8220;Merger
Parties&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Precision
Healing is developing a diagnostic imaging and smart pad for assessing a patient&#8217;s wound and skin conditions. This comprehensive
skin and wound assessment technology is designed to quantify biochemical markers to determine the trajectory of a wound&#8217;s condition
to enable better diagnosis and treatment protocol. To date, Precision Healing has not generated revenues. As previously disclosed, UWSS
purchased Series A Convertible Preferred Stock of Precision Healing from 2020 through 2021 for an aggregate purchase price of approximately
$2.8 million, resulting in the Company owning 25.7% of Precision Healing on a fully diluted basis prior to the Merger (defined below).
Prior to the Merger, the Company entered into agreements with Precision Healing, pursuant to which UWSS began integrating the
Precision Healing platform into the WounDerm electronic medical record.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2022 (the &#8220;Closing Date&#8221;), the Merger Parties closed the transactions contemplated by the Merger Agreement and effected
a business combination wherein Merger Sub I merged with and into Precision Healing, with Precision Healing being the surviving entity
and becoming a wholly owned subsidiary of UWSS and an indirect subsidiary of the Company (the &#8220;Merger&#8221;). In addition, as
part of the same overall transaction, the surviving entity of the First Merger has merged with and into Merger Sub II, with Merger Sub
II being the surviving entity and continuing as a wholly owned subsidiary of UWSS and an indirect subsidiary of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Merger Agreement,
among other things, the Company agreed to (i) pay the holders of Precision Healing common stock and preferred stock an aggregate of approximately
$4.6 million, which is payable in cash or equity, (ii) pay approximately $0.6 million of transaction expenses on behalf of the equityholders
of Precision Healing, (iii) assume all outstanding options and warrants of Precision Healing and (iv) pay, subject to the achievement
of certain performance thresholds, earnout consideration, each as described in further detail below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Closing Consideration to Precision Healing Equityholders</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the terms of the Merger Agreement, holders of Precision Healing common stock and preferred stock issued and outstanding immediately
prior to the First Merger Effective Time (as defined in the Merger Agreement), other than UWSS, are entitled to receive up to approximately
$5.1 million as aggregate closing consideration, which is anticipated to consist of $125,965 in cash consideration primarily payable
to stockholders who are not accredited investors, 165,738 shares of Company common stock (the &#8220;Closing Shares&#8221;) payable only
to &#8220;accredited investors&#8221; as such term is defined in Rule 501(a) of Regulation D promulgated under the Securities Act of
1933, as amended (the &#8220;Securities Act&#8221;), and the payment in cash of approximately $0.6 million of transaction
expenses of Precision Healing. The final breakdown of the closing consideration between cash consideration and Closing Shares, with
such shares being issued at a trailing average closing price of $27.13 per share, is subject to change based upon the determination
of whether Precision Healing stockholders are accredited investors and upon the receipt by the Company of accredited investor questionnaires
from Precision Healing stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Assumption of Precision Healing Options and
Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On the Closing Date, the Precision
Healing options previously granted under any plan or agreement, including the Precision Healing 2020 Stock Option and Grant Plan (the
&#8220;Precision Plan&#8221;), and outstanding immediately prior to the First Merger Effective Time converted pursuant to their terms
into options to acquire, on the same terms and conditions as were applicable under such Precision Healing options immediately prior to
the First Merger Effective Time, an aggregate of 144,191 shares of Company common stock with a weighted exercise price of $10.71 per
share (the &#8220;Merger Options&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition, on the Closing
Date each Precision Healing warrant that was outstanding and unexercised immediately prior to the First Merger Effective Time was converted
into the right to receive a warrant to purchase Company common stock. Accordingly, on the Closing Date the Company issued Blue IO (i)
a common stock warrant to purchase up to 4,424 shares of Company common stock with an initial exercise price of $7.32 per share and an
expiration date of April 22, 2031 and (ii) a common stock warrant to purchase up to 12,301 shares of Company common stock with an initial
exercise price of $12.05 per share and an expiration date of August 10, 2030 (such warrants, the &#8220;Sanara Common Stock Warrants&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Sanara Common Stock Warrants does not purport to be complete and is qualified in its entirety to the complete text of the Sanara
Common Stock Warrants, copies of which are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K (&#8220;Current Report&#8221;)
and are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Assumption of the Precision Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the Merger Agreement,
the Company assumed sponsorship of the Precision Plan, effective as of the Closing Date, as well as the outstanding awards granted thereunder,
the award agreements evidencing the grants of such awards and the remaining shares available under the Precision Plan, in each case adjusted
in the manner set forth in the Merger Agreement to such awards. Concurrent with the assumption of the Precision Plan, the Company terminated
the ability to offer future awards under the Precision Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The foregoing description
of the Precision Plan does not purport to be complete and is qualified in its entirety to the complete text of the Precision Plan, a
copy of which is filed as Exhibits 10.3 to this Current Report and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Earnout Consideration</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
previously disclosed, upon the achievement of certain performance thresholds, the securityholders of Precision Healing, including the
holders of options and warrants to purchase Precision Healing common stock and certain persons promised options to purchase Precision
Healing common stock, are also entitled to receive payments of up to $10.0 million (the &#8220;Earnout Consideration&#8221;), which is
payable in cash or, at the Company&#8217;s election, is payable to accredited investors in shares of Company common stock (the &#8220;Earnout
Shares&#8221; and collectively with the Closing Shares, the &#8220;Merger Shares&#8221;) at a price per share equal to the greater of
(i) $27.13 and (ii) the average closing price of Company common stock for the 20 trading days prior to the date such Earnout Consideration
is due and payable. Pursuant to the Merger Agreement, a minimum percentage of the Earnout Consideration may be required to be issued
to accredited investors in shares of common stock for tax purposes. The amount and composition of the portion of Earnout Consideration
payable is subject to adjustment and offsets as set forth in the Merger Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety to the complete text of
the Merger Agreement, a copy of which is filed as Exhibit 2.1 to this Current Report and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.01 Completion of Acquisition or Disposition of Assets.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 regarding the Merger is incorporated by reference into this Item 2.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02 Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth under Item 1.01 with respect to the issuance of the Merger Shares and Sanara Common Stock Warrants to Precision
Healing securityholders pursuant to the Merger Agreement is incorporated herein by reference. As discussed above, only Precision Healing
stockholders who are accredited investors and who deliver a properly completed accredited investor questionnaire will have the right
to receive Merger Shares as part of the consideration for the Merger. All other Precision Healing stockholders will receive cash. The
final number of Merger Shares to be issued is subject to change based upon the determination of whether such Precision Healing stockholders
are accredited investors. The issuance of the Merger Shares is being undertaken in reliance upon the exemption from the registration
requirements of the Securities Act, pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Merger Agreement, on the Closing Date, each Precision Healing warrant that was outstanding and unexercised immediately prior to
the First Merger Effective Time was converted into the right to receive a warrant to purchase Company common stock, including the following:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">&#9679;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    common stock warrant issued to Blue IO to purchase up to 4,424 shares of Company common stock with an initial exercise price of $7.32
    per share and an expiration date of April 22, 2031; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    common stock warrant issued to Blue IO to purchase up to 12,301 shares of Company common stock with an initial exercise price of
    $12.05 per share and an expiration date of August 10, 2030.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuance of the Sanara Common Stock Warrants was undertaken in reliance upon the exemption from the registration requirements of the
Securities Act, pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder. In addition, the issuance of
the shares exercisable upon the exercise of the Sanara Common Stock Warrants will be undertaken in reliance upon the exemption from the
registration requirements of the Securities Act, pursuant to Section 4(a)(2) thereof and Rule 506 of Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, on the Closing Date, the Precision Healing options previously granted under any plan or agreement, including the Precision
Plan, and outstanding immediately prior to the First Merger Effective Time converted pursuant to their terms into options to acquire,
on the same terms and conditions as were applicable under such Precision Healing options immediately prior to the First Merger Effective
Time, an aggregate of 144,191 shares of Company common stock with a weighted exercise price of $10.71 per share. Pursuant to the terms
of the Merger Agreement, the Company shall, as soon as reasonably practicable following the First Merger Effective Time, file with the
Securities and Exchange Commission a registration statement on Form S-8 relating to the shares of Company common stock issuable with
respect to Merger Options assumed by the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 4, 2022, the Company issued a press release announcing the closing of the Merger. A copy of the press release is furnished as Exhibit
99.1 to this Current Report and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information included under Item 7.01 (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise be subject to the liabilities
of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, whether
made before or after the date hereof and regardless of any general incorporation language in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Information
About Forward-Looking Statements</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
statements in this Current Report that do not constitute historical facts are &#8220;forward-looking statements,&#8221; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &#8220;aim,&#8221; &#8220;anticipates,&#8221; &#8220;believe,&#8221; contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221;
&#8220;preliminary,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;target,&#8221; &#8220;should,&#8221; &#8220;will&#8221;
or &#8220;would, or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements
include statements regarding the number of Merger Shares issuable and amount of cash payable as closing consideration pursuant to the
Merger Agreement. These items involve risks, contingencies and uncertainties including the determination of whether investors are accredited,
which could cause actual results to differ materially from those expressed in, or implied by, these statements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Financial Statements of Business Acquired.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent required, the Company intends to file the financial statements required by Item 9.01(a), with respect to the Merger described
in Item 2.01 herein, by amendment to this Current Report as soon as practicable and in any event not later than 71 days after the date
on which this Current Report is required to be filed pursuant to Item 2.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Pro Forma Financial Information.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent required, the Company intends to file the pro forma financial information required by Item 9.01(b), with respect to the Merger
described in Item 2.01 herein, by amendment to this Current Report as soon as practicable and in any event not later than 71 days after
the date on which this Current Report is required to be filed pursuant to Item 2.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1*</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="https://www.sec.gov/Archives/edgar/data/714256/000149315222008931/ex2-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement and Plan of Merger, dated April 1, 2022, by and among Sanara MedTech Inc., United Wound and Skin Solutions, LLC, Precision Healing Inc., PH Merger Sub I, Inc., PH Merger Sub II, LLC and Furneaux Capital Holdco, LLC (d/b/a BlueIO) (incorporated by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on April 4, 2022).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock Warrant, issued by Sanara MedTech Inc. to Furneaux Capital Holdco, LLC (d/b/a BlueIO) on April 4, 2022. </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-2.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common Stock Warrant, issued by Sanara MedTech Inc. to Furneaux Capital Holdco, LLC (d/b/a BlueIO) on April 4, 2022.</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex10-3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Precision Healing Inc. 2020 Stock Option and Grant Plan </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release of Sanara MedTech Inc., dated April 4, 2022 (furnished pursuant to Item 7.01). </span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted
exhibit or schedule will be furnished supplementally to the SEC or its staff upon request.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    8, 2022</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sanara
    MedTech Inc</b>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Michael D. McNeil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OUq3hPCtpCKyCInodckxlnRHZjfLT+ov25RoGBiGe8+9QozEhta6QobLMs/ghHVTKYeQY4mM5orekW53Cfib401bx8q4/v2BKXkGPROPo6nyQm9ttcUigXA2CecTKSGSSRzDYi+Cr56SKXWBxmlVgTIFHJka1ugUd0PCSb3IUN31VWdkq8kkEI3DQX6DDCMJB2rVk/huIctSEYz6CcSG6dF8ax7WUQ2rCmvfZQf0v8EHEbBJPg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
WARRANT EVIDENCED HEREBY, AND THE SECURITIES ISSUABLE HEREUNDER, HAVE BEEN AND SHALL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE &ldquo;<U>ACT</U>&rdquo;) OR THE APPLICABLE STATE SECURITIES LAWS. THE WARRANT AND SUCH SECURITIES HAVE
BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND SHALL NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED,
OTHER THAN IN ACCORDANCE WITH SECTION 13, UNLESS THE PROPOSED DISPOSITION IS THE SUBJECT OF A CURRENTLY EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE
REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT AND SUCH STATE SECURITIES
LAWS IN CONNECTION WITH SUCH DISPOSITION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT, AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT, ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND OTHER PROVISIONS SET
FORTH IN THIS WARRANT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
MEDTECH INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
Issue Date: April 4, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Void
After: 5 PM Eastern Time on April 22, 2031</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Warrant Is Issued to</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furneaux
Capital Holdco, LLC (DBA BlueIO)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hereinafter
called the &ldquo;<U>Holder</U>,&rdquo; which term shall include the Holder&rsquo;s legal representatives, heirs, successors and permitted
assigns) by Sanara MedTech Inc., a Texas corporation (hereinafter referred to as the &ldquo;<U>Company</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby certifies as of the Original Issue Date that, for value received, the Holder is entitled, subject to the terms and conditions
set forth in this Warrant, to purchase from the Company, at any time on or after the Original Issue Date and in any event not after the
Expiration Date (as defined below), 4,424 duly authorized, validly issued, fully paid, nonassessable shares of the Company&rsquo;s Common
Stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), at an initial purchase price per share equal to $7.32 per
share. The number of shares of Common Stock and the purchase price thereof shall be adjusted or readjusted from time to time as provided
in this Warrant (as so adjusted, the &ldquo;<U>Warrant Shares</U>&rdquo; and the &ldquo;<U>Exercise Price</U>&rdquo;, respectively).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Expiration
Date</U>&rdquo; means 5 PM Eastern Time on April 22, 2031.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
    of Warrant</U>. The Holder may exercise this Warrant, in whole or in part (except as to a fractional share), during the period beginning
    on the Original Issue Date and ending on the Expiration Date, by (i) delivering a subscription agreement, in the form attached hereto
    as <U>Exhibit A</U> (the &ldquo;<U>Subscription Form</U>&rdquo;), duly executed by the Holder, specifying the number of Warrant Shares
    to be issued to the Holder as a result of such exercise, (ii) surrendering this Warrant to the Company, properly endorsed by the
    Holder (or if this Warrant has been destroyed, stolen or has otherwise been misplaced, by delivering to the Company an affidavit
    of loss duly executed by the Holder), and (iii) tendering payment for the shares of Common Stock designated by the Exercise Notice
    in lawful money of the United States in the form of cash, bank or certified check made payable to the order of the Company, or by
    wire transfer of immediately available funds, or by the cancellation of indebtedness of the Company owed to the Holder, or in any
    combination thereof, of the applicable Exercise Price as to which this Warrant is being exercised.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Net
    Exchange</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Generally</U>.
    The Holder may, in lieu of exercising this Warrant pursuant to the terms of Section 1, elect to exchange this Warrant at any time
    prior to the Expiration Date by delivering to the Company a written notice, in the form attached hereto as <U>Exhibit B</U> (the
    &ldquo;<U>Exchange Notice</U>&rdquo;), duly executed by the Holder, specifying the number of Warrant Shares to be issued to the Holder
    as a result of such exchange. The Holder shall thereupon be entitled to receive the number of Warrant Shares equal to the product
    of (i) the number of Warrant Shares issuable upon exercise of this Warrant (or, if only a portion of this Warrant is being exercised,
    issuable upon the exercise of such portion) for cash, and (ii) a fraction, the numerator of which is the Fair Market Value (as defined
    below) per share of Common Stock at the time of such exercise <I>minus </I>the Exercise Price in effect at the time of such exercise,
    and the denominator of which is the Fair Market Value per share of Common Stock at the time of such exercise, such number of shares
    so issuable upon such exchange to be rounded down to the nearest whole number of shares of Common Stock with any excess at the option
    of the Holder to be forfeited or to be paid in cash by the Company to the Holder. For all purposes of this Warrant (other than Section
    1 and this Section 2), any reference herein to the &ldquo;exercise&rdquo; of this Warrant shall be deemed to include a reference
    to the exchange of this Warrant for Common Stock in accordance with the terms of this Section 2. For purposes of this Section 2,
    &ldquo;<U>Fair Market Value</U>&rdquo; shall mean the fair market value of one share of Common Stock as determined by the Board of
    Directors, in good faith.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Automatic</U>.
    To the extent not previously exercised in full pursuant to Section 1 or exchanged in full pursuant to Section 2(a), this Warrant
    shall, unless the Holder shall have previously notified the Company in writing of the Holder&rsquo;s waiver of this Section 2(b),
    automatically be deemed to have been fully exchanged pursuant to the terms of Section 2(a) as of immediately before any expiration,
    termination or cancellation of this Warrant, if at such time the Fair Market Value per share of Common Stock (or other security issuable
    upon the exercise hereof) exceeds the per share Exercise Price, even if the Holder does not deliver an Exchange Notice or surrender
    this Warrant to the Company in connection therewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Issuance
    of Stock Certificates</U>. As promptly as practicable after exercise or exchange and surrender of this Warrant and receipt of payment
    of the aggregate Exercise Price (if applicable), the Company shall issue and deliver to the Holder a certificate or certificates
    for the shares purchased hereunder in the name of the Holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustment
    for Dividends, Distributions, Subdivisions, Combinations, Mergers, Consolidations or Sale of Assets</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Manner
    of Adjustment</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
    Dividends, Distributions or Subdivisions</U>. In the event the Company shall issue shares of capital stock in a stock dividend, stock
    distribution or subdivision in respect of its Common Stock, the Exercise Price in effect immediately before such stock dividend,
    stock distribution or subdivision shall, concurrently with the effectiveness of such stock dividend, stock distribution or subdivision,
    be proportionately decreased and the number of Warrant Shares shall be proportionately increased.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Combinations
    or Consolidations</U>. In the event the outstanding shares of Common Stock shall be combined or consolidated, by reclassification
    or otherwise, into a lesser number of shares of Common Stock, the Exercise Price in effect immediately prior to such combination
    or consolidation shall, concurrently with the effectiveness of such combination or consolidation, be proportionately increased and
    the number of Warrant Shares shall be proportionately decreased.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustment
    for Reclassification, Exchange or Substitution</U>. In the event that the class of securities issuable upon the exercise of this
    Warrant shall be changed into the same or a different number of shares of any class or classes of stock, whether by capital reorganization,
    reclassification or otherwise (other than any event addressed by Sections 4.1(a) or 4.1(b)), then and in each such event the Holder
    shall have the right thereafter to exercise this Warrant for the kind and amount of shares of stock and other securities and property
    receivable upon such reorganization, reclassification, or other change, by holders of the number of shares of the class of securities
    into which such Warrant might have been exercisable for immediately prior to such reorganization, reclassification, or change, all
    subject to further adjustment as provided herein.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustment
    for Merger, Consolidation or Sale of Assets</U>. In the event that the Company shall merge or consolidate with or into another entity
    or sell all or substantially all of its assets (an &ldquo;<U>Acquisition</U>&rdquo;), this Warrant shall thereafter be exercisable
    for the kind and amount of shares of stock or other securities or property to which a holder of the Warrant Shares would have been
    entitled upon such Acquisition; and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors)
    shall be made in the application of the provisions set forth in this Section 4 with respect to the rights and interest thereafter
    of the Holder of this Warrant, to the end that the provisions set forth in this Section 4 shall thereafter be applicable, as nearly
    as reasonably may be, in relation to any shares of stock or other property thereafter deliverable upon the exercise of this Warrant.
    Notwithstanding the foregoing sentence, a transaction shall not constitute an Acquisition if the primary purpose is to change the
    jurisdiction of the Company&rsquo;s incorporation, create a holding company that will be owned in substantially the same proportions
    by the persons who held the Company&rsquo;s securities immediately before such transaction, or engage in a bona fide equity financing
    transaction</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Certificate
    as to Adjustments</U>. Upon the occurrence of each adjustment or readjustment of the Exercise Price pursuant to this Section 4, the
    Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to
    the Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment
    or readjustment is based.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Closing
    of Books</U>. The Company shall at no time close its transfer books against the transfer of any of Warrant Shares in any manner which
    interferes with the timely and proper issuance of such shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations
    of Holder</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Acquisition
    of Warrant for Personal Account</U>. The Holder represents and warrants that it is acquiring the Warrant and the Warrant Shares solely
    for its account for investment and not with a view to or for sale or distribution of said Warrant or Warrant Shares or any part thereof.
    The Holder also represents that the entire legal and beneficial interests of the Warrant and Warrant Shares the Holder is acquiring
    is being acquired for, and will be held for, its account only.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Investment
    Experience; Accredited Investor</U>. Holder understands that the purchase of this Warrant and its underlying securities involves
    substantial risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that
    Holder can bear the economic risk of such Holder&rsquo;s investment in this Warrant and its underlying securities and has such knowledge
    and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this
    Warrant and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain of
    its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business
    acumen and financial circumstances of such persons. Holder is an &ldquo;accredited investor&rdquo; within the meaning of Regulation
    D promulgated under the Act.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Securities
    Are Not Registered</U>.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Holder understands that the Warrant and the Warrant Shares have not been registered under the Act on the basis that no distribution
    or public offering of the stock of the Company is to be effected. The Holder realizes that the basis for the exemption may not be
    present if, notwithstanding its representations, the Holder has a present intention of acquiring the securities for a fixed or determinable
    period in the future, selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing
    the securities. The Holder has no such present intention.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Holder recognizes that the Warrant and the Warrant Shares must be held indefinitely unless they are subsequently registered under
    the Act or an exemption from such registration is available. The Holder recognizes that the Company has no obligation to register
    the Warrant or the Warrant Shares of the Company, or to comply with any exemption from such registration.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Holder is aware that neither the Warrant nor the Warrant Shares may be sold pursuant to Rule 144 adopted under the Act unless certain
    conditions are met, including, among other things, the existence of a public market for the shares, the availability of certain current
    public information about the Company, the resale following the required holding period under Rule 144 and the number of shares being
    sold during any three month period not exceeding specified limitations. Holder is aware that the conditions for resale set forth
    in Rule 144 have not been satisfied and that the Company presently has no plans to satisfy these conditions in the foreseeable future.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notice
    of Certain Transactions</U>. If (i) the Company effects an Acquisition or (ii) the Company completes its first underwritten public
    offering of its Common Stock under the Act (each event identified in clauses (i) and (ii) referred herein to as a &ldquo;<U>Transaction</U>&rdquo;),
    in any case while this Warrant remains outstanding, the Company shall give the Holder written notice of such Transaction at least
    20 days prior to the effective date of such Transaction. If an exercise or exchange of this Warrant is made in connection with any
    Transaction, such exercise or exchange may, at the Holder&rsquo;s election, be conditioned upon the consummation of such Transaction,
    in which case such exercise or exchange shall not be deemed to be effective until immediately prior to the consummation of such Transaction.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Covenants
    of the Company</U>. During the period within which the rights represented by this Warrant may be exercised, the Company shall at
    all times have authorized and reserved for the purpose of issue upon exercise of the rights evidenced hereby, a sufficient number
    of shares of the class of securities issuable upon exercise of this Warrant to provide for the exercise of such rights. All securities
    which may be issued upon the exercise of the rights represented by this Warrant shall, upon issuance, be duly authorized, validly
    issued, fully paid and non-assessable and free from all taxes, liens and charges with respect to the issue thereof. Upon surrender
    for exercise, this Warrant shall be canceled and shall not be reissued; <U>provided</U>, <U>however</U>, that upon the partial exercise
    hereof a substitute Warrant of like tenor and date representing the rights to subscribe for and purchase any such unexercised portion
    hereof shall be issued.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Voting
    Rights</U>. This Warrant shall not entitle the Holder to any voting rights or any other rights as a stockholder of the Company but
    upon presentation of this Warrant with the Subscription Form or Exchange Notice duly executed and the tender of payment of the aggregate
    Exercise Price (if applicable) at the office of the Company pursuant to the provisions of this Warrant, the Holder shall forthwith
    be deemed a stockholder of the Company in respect of the securities for which the Holder has so subscribed and paid or exchanged.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Change Necessary</U>. The form of this Warrant need not be changed because of any adjustment in the Exercise Price or in the number
    of Warrant Shares. A Warrant issued after any adjustment or any partial exercise or upon replacement may continue to express the
    same Exercise Price and the same number of Warrant Shares (appropriately reduced in the case of partial exercise) as are stated on
    this Warrant as initially issued, and that Exercise Price and that number of Warrant Shares shall be considered to have been so changed
    as of the close of business on the date of adjustment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices
    to Holder</U>. If at any time prior to the expiration of this Warrant and prior to its exercise, any of the following events shall
    occur:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend or distribution
    payable otherwise than out of current or retained earnings, as indicated by the accounting treatment of such dividend or distribution
    on the books of the Company; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consummation of a Transaction; then, in any one or more of said events, the Company shall give to the Holder written notice of such
    event. Such notice shall set forth the date on which such event shall take place, shall if applicable specify the deadline date as
    of which the holders of Common Stock of record shall be entitled or required to take any action, or the record date with respect
    to any dividend, and shall be given at least twenty (20) days prior to the deadline or record date. Failure to give such notice or
    any defect therein shall not affect the validity of any action taken in connection with the declaration or payment of any such dividend
    or the making of any such distribution or any action in connection with any such proposed Transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Addresses
    for Notices</U>. All notices, requests, consents and other communications hereunder shall be in writing, either delivered in hand
    or mailed by registered or certified mail, return receipt requested, or sent by facsimile, and shall be deemed to have been duly
    made when delivered:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Holder, to the Holder&rsquo;s address as shown on the books of the Company; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Company, to Sanara MedTech Inc., Attn: Corporate Secretary at the Company&rsquo;s principal executive office.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Substitution</U>.
    In the case this Warrant shall be mutilated, lost, stolen or destroyed, the Company shall issue a new Warrant of like tenor and denomination
    and deliver the same (a) in exchange and substitution for and upon surrender and cancellation of any mutilated Warrant, or (b) in
    lieu of any Warrant lost, stolen or destroyed, upon receipt of evidence satisfactory to the Company of the loss, theft, or destruction
    of such Warrant (including, without limitation, a reasonably detailed affidavit with respect to the circumstances of any loss, theft
    or destruction), and of indemnity (or, in the case of the initial Holder or any other institutional holder, an indemnity agreement)
    satisfactory to the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
    Restrictions</U>. This Warrant shall be exercisable only by the Holder. Without the prior written consent of the Company, this Warrant
    shall not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be
    subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition
    of this Warrant or of any rights granted hereunder contrary to the provisions of this Section 13, or the levy of any attachment or
    similar process upon this Warrant or such rights, shall be null and void. Notwithstanding the foregoing, the Holder may transfer
    this Warrant in full to an affiliate or to a successor entity of the Holder or acquirer of the Holder in the event of a merger or
    consolidation or sale of substantially all of the assets of the Holder, provided that (1) the transferee shall be in writing bound
    by and subject to all the obligations and entitled to all the benefits of this Warrant as the &ldquo;Holder&rdquo; hereunder and
    (2) the Company obtains prior assurances reasonably satisfactory to the Company that such transfer is exempt from the registration
    requirements of, or is covered by an effective registration statement under, the Act and applicable state securities or &ldquo;blue
    sky&rdquo; laws, including, without limitation, receipt of an opinion to such effect of counsel reasonably satisfactory to the Company.
    The Holder understands and agrees that all certificates evidencing the shares to be issued to the Holder in connection with this
    Warrant may bear the following legend:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR UNDER THE SECURITIES
LAWS OF APPLICABLE STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR
RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION UNDER SUCH LAWS OR AN
EXEMPTION FROM SUCH REGISTRATION REQUIREMENT. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF
THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ALL
APPLICABLE STATE SECURITIES LAWS.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Taxes</U>.
    The Company makes no representation about tax treatment to the Holder with respect to receipt or exercise of this Warrant or acquiring,
    holding or disposing of the Warrant Shares, and the Holder represents that the Holder has had the opportunity to discuss such treatment
    with the Holder&rsquo;s tax advisers.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Remedies</U>.
    Each party stipulates that the remedies at law in the event of any default or threatened default by the other party in the performance
    or compliance with any of the terms of this Warrant are and shall not be adequate, and that such terms may be specifically enforced
    by a decree for that specific performance of any agreement contained herein or by an injunction against a violation of any of the
    terms hereof or otherwise.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing
    Law</U>. This Warrant and any controversy arising out of or relating to this Warrant shall be governed by and construed in accordance
    with the internal laws of the State of Texas.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Miscellaneous</U>.
    This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the
    party against which enforcement of such change, waiver, discharge or termination is sought. The invalidity or unenforceability of
    any provision hereof shall in no way affect the validity or enforceability of any other provision.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[remainder
of page intentionally left blank]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed effective as of the Original Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
    MEDTECH INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ATTEST:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Furneaux
    Capital Holdco, LLC (DBA BlueIO)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dave Furneaux</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave
Furneaux</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE TO COMMON STOCK WARRANT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
A</U></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Form</FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be Executed by the Holder in Order to Exercise the Warrant<FONT STYLE="font-weight: normal">)</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, pursuant to the provisions set forth in the attached Warrant hereby irrevocably elects to purchase _____ shares of the Common
Stock of the Company (the &ldquo;<U>Common Stock</U>&rdquo;) covered by such Warrant and herewith makes payment of $__, representing the
[full/partial] purchase price for such shares at the price per share provided for in such Warrant. Capitalized terms defined, but not
used, herein shall have the meanings ascribed to them in such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby agrees to take such other action and execute and deliver such other documents as the Company may require, in connection
with the issue of shares of Common Stock to the undersigned as aforesaid, in order to comply with the provisions of such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned is aware that the shares of Common Stock issuable upon exercise hereof (the &ldquo;<U>Shares</U>&rdquo;) have not been registered
under the Act or any state securities laws. The undersigned understands that the reliance by the Company on exemptions under the Act
is predicated in part upon the truth and accuracy of the statements of the undersigned in this Subscription Form and such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned represents and warrants that (1) it has been furnished with all information which it deems necessary to evaluate the merits
and risks of the purchase of the Shares, (2) it has had the opportunity to ask questions concerning the Shares and the Company and all
questions posed have been answered by the Company to its satisfaction, (3) it has been given the opportunity to obtain any additional
information it deems necessary to verify the accuracy of any information obtained concerning the Shares and the Company, (4) it has such
knowledge and experience in financial and business matters that it is able to evaluate the merits and risks of purchasing the Shares
and to make an informed investment decision relating thereto, and (5) it is an &ldquo;Accredited Investor&rdquo; as defined in Rule 501(a)
of Regulation D under the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that it is purchasing the Shares for its own account and not with a view to the sale or distribution
of all or any part of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that because the Shares have not been registered under the Act, it must continue to bear the economic risk of
the investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable federal
and state securities laws or an exemption from such registration is available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees that it shall in no event sell or distribute or otherwise dispose of all or any part of the Shares unless (1) there
is an effective registration statement under the Act and applicable state securities laws covering any such transaction involving the
Shares or (2) the Company receives an opinion of legal counsel to the undersigned (concurred in by legal counsel for the Company) stating
that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned consents to the placing of a legend on its certificate for the Shares stating that the Shares has not been registered and
setting forth the restriction on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company
and with any transfer agents against the Shares until the Shares may be legally resold or distributed without restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned has considered the Federal and state income and other tax implications of the exercise of the Warrant and the purchase and
subsequent sale of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed
    Name of Holder (Must conform in</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    respects to name of Holder as specified on the face of such Warrant)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Signatory (for an entity only)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Signatory (for an entity only)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
B</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exchange
Notice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(To
be Executed by the Holder in Order to Exchange the Warrant)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, pursuant to the provisions set forth in the attached Warrant hereby irrevocably elects to exchange such Warrant with respect
to shares of the Common Stock of the Company (the &ldquo;Common Stock&rdquo;) covered by such Warrant which such Holder would be entitled
to receive upon the exercise thereof. Capitalized terms defined, but not used, herein shall have the meanings ascribed to them in such
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby agrees to take such other action and execute and deliver such other documents as the Company may require, in connection
with the issue of shares of Common Stock to the undersigned as aforesaid, in order to comply with the provisions of such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned is aware that the shares of Common Stock issuable upon exercise hereof (the &ldquo;Shares&rdquo;) have not been registered
under the Act or any state securities laws. The undersigned understands that the reliance by the Company on exemptions under the Act
is predicated in part upon the truth and accuracy of the statements of the undersigned in this Subscription Form and such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned represents and warrants that (1) it has been furnished with all information which it deems necessary to evaluate the merits
and risks of the receipt of the Shares, (2) it has had the opportunity to ask questions concerning the Shares and the Company and all
questions posed have been answered by the Company to its satisfaction, (3) it has been given the opportunity to obtain any additional
information it deems necessary to verify the accuracy of any information obtained concerning the Shares and the Company, (4) it has such
knowledge and experience in financial and business matters that it is able to evaluate the merits and risks of receiving the Shares and
to make an informed investment decision relating thereto, and (5) it is an &ldquo;Accredited Investor&rdquo; as defined in Rule 501(a)
of Regulation D under the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that it is receiving the Shares for its own account and not with a view to the sale or distribution
of all or any part of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that because the Shares have not been registered under the Act, it must continue to bear the economic risk of
the investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable federal
and state securities laws or an exemption from such registration is available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees that it shall in no event sell or distribute or otherwise dispose of all or any part of the Shares unless (1) there
is an effective registration statement under the Act and applicable state securities laws covering any such transaction involving the
Shares or (2) the Company receives an opinion of legal counsel to the undersigned (concurred in by legal counsel for the Company) stating
that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned consents to the placing of a legend on its certificate for the Shares stating that the Shares have not been registered and
setting forth the restriction on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company
and with any transfer agents against the Shares until the Shares may be legally resold or distributed without restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned has considered the Federal and state income and other tax implications of the exchange of the Warrant and the receipt and
subsequent sale of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed
    Name of Holder (Must conform in</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    respects to name of Holder as specified on the face of such Warrant)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Signatory (for an entity only)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Signatory (for an entity only)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 245.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THE
WARRANT EVIDENCED HEREBY, AND THE SECURITIES ISSUABLE HEREUNDER, HAVE BEEN AND SHALL BE ISSUED WITHOUT REGISTRATION UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE &ldquo;<U>ACT</U>&rdquo;) OR THE APPLICABLE STATE SECURITIES LAWS. THE WARRANT AND SUCH SECURITIES HAVE
BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND SHALL NOT BE SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED,
OTHER THAN IN ACCORDANCE WITH SECTION 13, UNLESS THE PROPOSED DISPOSITION IS THE SUBJECT OF A CURRENTLY EFFECTIVE REGISTRATION STATEMENT
UNDER THE ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL, IN FORM AND SUBSTANCE
REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT AND SUCH STATE SECURITIES
LAWS IN CONNECTION WITH SUCH DISPOSITION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT, AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT, ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND OTHER PROVISIONS SET
FORTH IN THIS WARRANT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
MEDTECH INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMMON
STOCK WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
Issue Date: April 4, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Void
After: 5 PM Eastern Time on August 10, 2030</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Warrant Is Issued to</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furneaux
Capital Holdco, LLC (DBA BlueIO)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hereinafter
called the &ldquo;<U>Holder</U>,&rdquo; which term shall include the Holder&rsquo;s legal representatives, heirs, successors and permitted
assigns) by Sanara MedTech Inc., a Texas corporation (hereinafter referred to as the &ldquo;<U>Company</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby certifies as of the Original Issue Date that, for value received, the Holder is entitled, subject to the terms and conditions
set forth in this Warrant, to purchase from the Company, at any time on or after the Original Issue Date and in any event not after the
Expiration Date (as defined below), 12,301 duly authorized, validly issued, fully paid, nonassessable shares of the Company&rsquo;s Common
Stock, par value $0.001 per share (the &ldquo;<U>Common Stock</U>&rdquo;), at an initial purchase price per share equal to $12.05 per
share. The number of shares of Common Stock and the purchase price thereof shall be adjusted or readjusted from time to time as provided
in this Warrant (as so adjusted, the &ldquo;<U>Warrant Shares</U>&rdquo; and the &ldquo;<U>Exercise Price</U>&rdquo;, respectively).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Expiration
Date</U>&rdquo; means 5 PM Eastern Time on August 10, 2030.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exercise
    of Warrant</U>. The Holder may exercise this Warrant, in whole or in part (except as to a fractional share), during the period beginning
    on the Original Issue Date and ending on the Expiration Date, by (i) delivering a subscription agreement, in the form attached hereto
    as <U>Exhibit A</U> (the &ldquo;<U>Subscription Form</U>&rdquo;), duly executed by the Holder, specifying the number of Warrant Shares
    to be issued to the Holder as a result of such exercise, (ii) surrendering this Warrant to the Company, properly endorsed by the
    Holder (or if this Warrant has been destroyed, stolen or has otherwise been misplaced, by delivering to the Company an affidavit
    of loss duly executed by the Holder), and (iii) tendering payment for the shares of Common Stock designated by the Exercise Notice
    in lawful money of the United States in the form of cash, bank or certified check made payable to the order of the Company, or by
    wire transfer of immediately available funds, or by the cancellation of indebtedness of the Company owed to the Holder, or in any
    combination thereof, of the applicable Exercise Price as to which this Warrant is being exercised.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Net
    Exchange</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Generally</U>.
    The Holder may, in lieu of exercising this Warrant pursuant to the terms of Section 1, elect to exchange this Warrant at any time
    prior to the Expiration Date by delivering to the Company a written notice, in the form attached hereto as <U>Exhibit B</U> (the
    &ldquo;<U>Exchange Notice</U>&rdquo;), duly executed by the Holder, specifying the number of Warrant Shares to be issued to the Holder
    as a result of such exchange. The Holder shall thereupon be entitled to receive the number of Warrant Shares equal to the product
    of (i) the number of Warrant Shares issuable upon exercise of this Warrant (or, if only a portion of this Warrant is being exercised,
    issuable upon the exercise of such portion) for cash, and (ii) a fraction, the numerator of which is the Fair Market Value (as defined
    below) per share of Common Stock at the time of such exercise <I>minus </I>the Exercise Price in effect at the time of such exercise,
    and the denominator of which is the Fair Market Value per share of Common Stock at the time of such exercise, such number of shares
    so issuable upon such exchange to be rounded down to the nearest whole number of shares of Common Stock with any excess at the option
    of the Holder to be forfeited or to be paid in cash by the Company to the Holder. For all purposes of this Warrant (other than Section
    1 and this Section 2), any reference herein to the &ldquo;exercise&rdquo; of this Warrant shall be deemed to include a reference
    to the exchange of this Warrant for Common Stock in accordance with the terms of this Section 2. For purposes of this Section 2,
    &ldquo;<U>Fair Market Value</U>&rdquo; shall mean the fair market value of one share of Common Stock as determined by the Board of
    Directors, in good faith.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Automatic</U>.
    To the extent not previously exercised in full pursuant to Section 1 or exchanged in full pursuant to Section 2(a), this Warrant
    shall, unless the Holder shall have previously notified the Company in writing of the Holder&rsquo;s waiver of this Section 2(b),
    automatically be deemed to have been fully exchanged pursuant to the terms of Section 2(a) as of immediately before any expiration,
    termination or cancellation of this Warrant, if at such time the Fair Market Value per share of Common Stock (or other security issuable
    upon the exercise hereof) exceeds the per share Exercise Price, even if the Holder does not deliver an Exchange Notice or surrender
    this Warrant to the Company in connection therewith.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Issuance
    of Stock Certificates</U>. As promptly as practicable after exercise or exchange and surrender of this Warrant and receipt of payment
    of the aggregate Exercise Price (if applicable), the Company shall issue and deliver to the Holder a certificate or certificates
    for the shares purchased hereunder in the name of the Holder.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustment
    for Dividends, Distributions, Subdivisions, Combinations, Mergers, Consolidations or Sale of Assets</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Manner
    of Adjustment</U>.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
    Dividends, Distributions or Subdivisions</U>. In the event the Company shall issue shares of capital stock in a stock dividend, stock
    distribution or subdivision in respect of its Common Stock, the Exercise Price in effect immediately before such stock dividend,
    stock distribution or subdivision shall, concurrently with the effectiveness of such stock dividend, stock distribution or subdivision,
    be proportionately decreased and the number of Warrant Shares shall be proportionately increased.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Combinations
    or Consolidations</U>. In the event the outstanding shares of Common Stock shall be combined or consolidated, by reclassification
    or otherwise, into a lesser number of shares of Common Stock, the Exercise Price in effect immediately prior to such combination
    or consolidation shall, concurrently with the effectiveness of such combination or consolidation, be proportionately increased and
    the number of Warrant Shares shall be proportionately decreased.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustment
    for Reclassification, Exchange or Substitution</U>. In the event that the class of securities issuable upon the exercise of this
    Warrant shall be changed into the same or a different number of shares of any class or classes of stock, whether by capital reorganization,
    reclassification or otherwise (other than any event addressed by Sections 4.1(a) or 4.1(b)), then and in each such event the Holder
    shall have the right thereafter to exercise this Warrant for the kind and amount of shares of stock and other securities and property
    receivable upon such reorganization, reclassification, or other change, by holders of the number of shares of the class of securities
    into which such Warrant might have been exercisable for immediately prior to such reorganization, reclassification, or change, all
    subject to further adjustment as provided herein.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Adjustment
    for Merger, Consolidation or Sale of Assets</U>. In the event that the Company shall merge or consolidate with or into another entity
    or sell all or substantially all of its assets (an &ldquo;<U>Acquisition</U>&rdquo;), this Warrant shall thereafter be exercisable
    for the kind and amount of shares of stock or other securities or property to which a holder of the Warrant Shares would have been
    entitled upon such Acquisition; and, in such case, appropriate adjustment (as determined in good faith by the Board of Directors)
    shall be made in the application of the provisions set forth in this Section 4 with respect to the rights and interest thereafter
    of the Holder of this Warrant, to the end that the provisions set forth in this Section 4 shall thereafter be applicable, as nearly
    as reasonably may be, in relation to any shares of stock or other property thereafter deliverable upon the exercise of this Warrant.
    Notwithstanding the foregoing sentence, a transaction shall not constitute an Acquisition if the primary purpose is to change the
    jurisdiction of the Company&rsquo;s incorporation, create a holding company that will be owned in substantially the same proportions
    by the persons who held the Company&rsquo;s securities immediately before such transaction, or engage in a bona fide equity financing
    transaction</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Certificate
    as to Adjustments</U>. Upon the occurrence of each adjustment or readjustment of the Exercise Price pursuant to this Section 4, the
    Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to
    the Holder a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment
    or readjustment is based.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Closing
    of Books</U>. The Company shall at no time close its transfer books against the transfer of any of Warrant Shares in any manner which
    interferes with the timely and proper issuance of such shares.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Representations
    of Holder</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Acquisition
    of Warrant for Personal Account</U>. The Holder represents and warrants that it is acquiring the Warrant and the Warrant Shares solely
    for its account for investment and not with a view to or for sale or distribution of said Warrant or Warrant Shares or any part thereof.
    The Holder also represents that the entire legal and beneficial interests of the Warrant and Warrant Shares the Holder is acquiring
    is being acquired for, and will be held for, its account only.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Investment
    Experience; Accredited Investor</U>. Holder understands that the purchase of this Warrant and its underlying securities involves
    substantial risk. Holder has experience as an investor in securities of companies in the development stage and acknowledges that
    Holder can bear the economic risk of such Holder&rsquo;s investment in this Warrant and its underlying securities and has such knowledge
    and experience in financial or business matters that Holder is capable of evaluating the merits and risks of its investment in this
    Warrant and its underlying securities and/or has a preexisting personal or business relationship with the Company and certain of
    its officers, directors or controlling persons of a nature and duration that enables Holder to be aware of the character, business
    acumen and financial circumstances of such persons. Holder is an &ldquo;accredited investor&rdquo; within the meaning of Regulation
    D promulgated under the Act.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Securities
    Are Not Registered</U>.</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Holder understands that the Warrant and the Warrant Shares have not been registered under the Act on the basis that no distribution
    or public offering of the stock of the Company is to be effected. The Holder realizes that the basis for the exemption may not be
    present if, notwithstanding its representations, the Holder has a present intention of acquiring the securities for a fixed or determinable
    period in the future, selling (in connection with a distribution or otherwise), granting any participation in, or otherwise distributing
    the securities. The Holder has no such present intention.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Holder recognizes that the Warrant and the Warrant Shares must be held indefinitely unless they are subsequently registered under
    the Act or an exemption from such registration is available. The Holder recognizes that the Company has no obligation to register
    the Warrant or the Warrant Shares of the Company, or to comply with any exemption from such registration.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Holder is aware that neither the Warrant nor the Warrant Shares may be sold pursuant to Rule 144 adopted under the Act unless certain
    conditions are met, including, among other things, the existence of a public market for the shares, the availability of certain current
    public information about the Company, the resale following the required holding period under Rule 144 and the number of shares being
    sold during any three month period not exceeding specified limitations. Holder is aware that the conditions for resale set forth
    in Rule 144 have not been satisfied and that the Company presently has no plans to satisfy these conditions in the foreseeable future.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notice
    of Certain Transactions</U>. If (i) the Company effects an Acquisition or (ii) the Company completes its first underwritten public
    offering of its Common Stock under the Act (each event identified in clauses (i) and (ii) referred herein to as a &ldquo;<U>Transaction</U>&rdquo;),
    in any case while this Warrant remains outstanding, the Company shall give the Holder written notice of such Transaction at least
    20 days prior to the effective date of such Transaction. If an exercise or exchange of this Warrant is made in connection with any
    Transaction, such exercise or exchange may, at the Holder&rsquo;s election, be conditioned upon the consummation of such Transaction,
    in which case such exercise or exchange shall not be deemed to be effective until immediately prior to the consummation of such Transaction.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Covenants
    of the Company</U>. During the period within which the rights represented by this Warrant may be exercised, the Company shall at
    all times have authorized and reserved for the purpose of issue upon exercise of the rights evidenced hereby, a sufficient number
    of shares of the class of securities issuable upon exercise of this Warrant to provide for the exercise of such rights. All securities
    which may be issued upon the exercise of the rights represented by this Warrant shall, upon issuance, be duly authorized, validly
    issued, fully paid and non-assessable and free from all taxes, liens and charges with respect to the issue thereof. Upon surrender
    for exercise, this Warrant shall be canceled and shall not be reissued; <U>provided</U>, <U>however</U>, that upon the partial exercise
    hereof a substitute Warrant of like tenor and date representing the rights to subscribe for and purchase any such unexercised portion
    hereof shall be issued.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Voting
    Rights</U>. This Warrant shall not entitle the Holder to any voting rights or any other rights as a stockholder of the Company but
    upon presentation of this Warrant with the Subscription Form or Exchange Notice duly executed and the tender of payment of the aggregate
    Exercise Price (if applicable) at the office of the Company pursuant to the provisions of this Warrant, the Holder shall forthwith
    be deemed a stockholder of the Company in respect of the securities for which the Holder has so subscribed and paid or exchanged.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Change Necessary</U>. The form of this Warrant need not be changed because of any adjustment in the Exercise Price or in the number
    of Warrant Shares. A Warrant issued after any adjustment or any partial exercise or upon replacement may continue to express the
    same Exercise Price and the same number of Warrant Shares (appropriately reduced in the case of partial exercise) as are stated on
    this Warrant as initially issued, and that Exercise Price and that number of Warrant Shares shall be considered to have been so changed
    as of the close of business on the date of adjustment.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Notices
    to Holder</U>. If at any time prior to the expiration of this Warrant and prior to its exercise, any of the following events shall
    occur:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend or distribution
    payable otherwise than out of current or retained earnings, as indicated by the accounting treatment of such dividend or distribution
    on the books of the Company; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    consummation of a Transaction; then, in any one or more of said events, the Company shall give to the Holder written notice of such
    event. Such notice shall set forth the date on which such event shall take place, shall if applicable specify the deadline date as
    of which the holders of Common Stock of record shall be entitled or required to take any action, or the record date with respect
    to any dividend, and shall be given at least twenty (20) days prior to the deadline or record date. Failure to give such notice or
    any defect therein shall not affect the validity of any action taken in connection with the declaration or payment of any such dividend
    or the making of any such distribution or any action in connection with any such proposed Transaction.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Addresses
    for Notices</U>. All notices, requests, consents and other communications hereunder shall be in writing, either delivered in hand
    or mailed by registered or certified mail, return receipt requested, or sent by facsimile, and shall be deemed to have been duly
    made when delivered:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Holder, to the Holder&rsquo;s address as shown on the books of the Company; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    to the Company, to Sanara MedTech Inc., Attn: Corporate Secretary at the Company&rsquo;s principal executive office.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Substitution</U>.
    In the case this Warrant shall be mutilated, lost, stolen or destroyed, the Company shall issue a new Warrant of like tenor and denomination
    and deliver the same (a) in exchange and substitution for and upon surrender and cancellation of any mutilated Warrant, or (b) in
    lieu of any Warrant lost, stolen or destroyed, upon receipt of evidence satisfactory to the Company of the loss, theft, or destruction
    of such Warrant (including, without limitation, a reasonably detailed affidavit with respect to the circumstances of any loss, theft
    or destruction), and of indemnity (or, in the case of the initial Holder or any other institutional holder, an indemnity agreement)
    satisfactory to the Company.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
    Restrictions</U>. This Warrant shall be exercisable only by the Holder. Without the prior written consent of the Company, this Warrant
    shall not be transferred, assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be
    subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition
    of this Warrant or of any rights granted hereunder contrary to the provisions of this Section 13, or the levy of any attachment or
    similar process upon this Warrant or such rights, shall be null and void. Notwithstanding the foregoing, the Holder may transfer
    this Warrant in full to an affiliate or to a successor entity of the Holder or acquirer of the Holder in the event of a merger or
    consolidation or sale of substantially all of the assets of the Holder, provided that (1) the transferee shall be in writing bound
    by and subject to all the obligations and entitled to all the benefits of this Warrant as the &ldquo;Holder&rdquo; hereunder and
    (2) the Company obtains prior assurances reasonably satisfactory to the Company that such transfer is exempt from the registration
    requirements of, or is covered by an effective registration statement under, the Act and applicable state securities or &ldquo;blue
    sky&rdquo; laws, including, without limitation, receipt of an opinion to such effect of counsel reasonably satisfactory to the Company.
    The Holder understands and agrees that all certificates evidencing the shares to be issued to the Holder in connection with this
    Warrant may bear the following legend:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;THESE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;ACT&rdquo;), OR UNDER THE SECURITIES
LAWS OF APPLICABLE STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR
RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION UNDER SUCH LAWS OR AN
EXEMPTION FROM SUCH REGISTRATION REQUIREMENT. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF
THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND
SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ALL
APPLICABLE STATE SECURITIES LAWS.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Taxes</U>.
    The Company makes no representation about tax treatment to the Holder with respect to receipt or exercise of this Warrant or acquiring,
    holding or disposing of the Warrant Shares, and the Holder represents that the Holder has had the opportunity to discuss such treatment
    with the Holder&rsquo;s tax advisers.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Remedies</U>.
    Each party stipulates that the remedies at law in the event of any default or threatened default by the other party in the performance
    or compliance with any of the terms of this Warrant are and shall not be adequate, and that such terms may be specifically enforced
    by a decree for that specific performance of any agreement contained herein or by an injunction against a violation of any of the
    terms hereof or otherwise.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Governing
    Law</U>. This Warrant and any controversy arising out of or relating to this Warrant shall be governed by and construed in accordance
    with the internal laws of the State of Texas.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Miscellaneous</U>.
    This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the
    party against which enforcement of such change, waiver, discharge or termination is sought. The invalidity or unenforceability of
    any provision hereof shall in no way affect the validity or enforceability of any other provision.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[remainder
of page intentionally left blank]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed effective as of the Original Issue Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
    MEDTECH INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Michael D. McNeil</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    D. McNeil</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ATTEST:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Furneaux
    Capital Holdco, LLC (DBA BlueIO)</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dave Furneaux</I></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave
Furneaux</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE TO COMMON STOCK WARRANT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
A</U></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Form</FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(To
be Executed by the Holder in Order to Exercise the Warrant<FONT STYLE="font-weight: normal">)</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, pursuant to the provisions set forth in the attached Warrant hereby irrevocably elects to purchase _____ shares of the Common
Stock of the Company (the &ldquo;<U>Common Stock</U>&rdquo;) covered by such Warrant and herewith makes payment of $__, representing the
[full/partial] purchase price for such shares at the price per share provided for in such Warrant. Capitalized terms defined, but not
used, herein shall have the meanings ascribed to them in such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby agrees to take such other action and execute and deliver such other documents as the Company may require, in connection
with the issue of shares of Common Stock to the undersigned as aforesaid, in order to comply with the provisions of such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned is aware that the shares of Common Stock issuable upon exercise hereof (the &ldquo;<U>Shares</U>&rdquo;) have not been registered
under the Act or any state securities laws. The undersigned understands that the reliance by the Company on exemptions under the Act
is predicated in part upon the truth and accuracy of the statements of the undersigned in this Subscription Form and such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned represents and warrants that (1) it has been furnished with all information which it deems necessary to evaluate the merits
and risks of the purchase of the Shares, (2) it has had the opportunity to ask questions concerning the Shares and the Company and all
questions posed have been answered by the Company to its satisfaction, (3) it has been given the opportunity to obtain any additional
information it deems necessary to verify the accuracy of any information obtained concerning the Shares and the Company, (4) it has such
knowledge and experience in financial and business matters that it is able to evaluate the merits and risks of purchasing the Shares
and to make an informed investment decision relating thereto, and (5) it is an &ldquo;Accredited Investor&rdquo; as defined in Rule 501(a)
of Regulation D under the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that it is purchasing the Shares for its own account and not with a view to the sale or distribution
of all or any part of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that because the Shares have not been registered under the Act, it must continue to bear the economic risk of
the investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable federal
and state securities laws or an exemption from such registration is available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees that it shall in no event sell or distribute or otherwise dispose of all or any part of the Shares unless (1) there
is an effective registration statement under the Act and applicable state securities laws covering any such transaction involving the
Shares or (2) the Company receives an opinion of legal counsel to the undersigned (concurred in by legal counsel for the Company) stating
that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned consents to the placing of a legend on its certificate for the Shares stating that the Shares has not been registered and
setting forth the restriction on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company
and with any transfer agents against the Shares until the Shares may be legally resold or distributed without restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned has considered the Federal and state income and other tax implications of the exercise of the Warrant and the purchase and
subsequent sale of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed
    Name of Holder (Must conform in</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    respects to name of Holder as specified on the face of such Warrant)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Signatory (for an entity only)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Signatory (for an entity only)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
B</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exchange
Notice</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(To
be Executed by the Holder in Order to Exchange the Warrant)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, pursuant to the provisions set forth in the attached Warrant hereby irrevocably elects to exchange such Warrant with respect
to shares of the Common Stock of the Company (the &ldquo;Common Stock&rdquo;) covered by such Warrant which such Holder would be entitled
to receive upon the exercise thereof. Capitalized terms defined, but not used, herein shall have the meanings ascribed to them in such
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby agrees to take such other action and execute and deliver such other documents as the Company may require, in connection
with the issue of shares of Common Stock to the undersigned as aforesaid, in order to comply with the provisions of such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned is aware that the shares of Common Stock issuable upon exercise hereof (the &ldquo;Shares&rdquo;) have not been registered
under the Act or any state securities laws. The undersigned understands that the reliance by the Company on exemptions under the Act
is predicated in part upon the truth and accuracy of the statements of the undersigned in this Subscription Form and such Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned represents and warrants that (1) it has been furnished with all information which it deems necessary to evaluate the merits
and risks of the receipt of the Shares, (2) it has had the opportunity to ask questions concerning the Shares and the Company and all
questions posed have been answered by the Company to its satisfaction, (3) it has been given the opportunity to obtain any additional
information it deems necessary to verify the accuracy of any information obtained concerning the Shares and the Company, (4) it has such
knowledge and experience in financial and business matters that it is able to evaluate the merits and risks of receiving the Shares and
to make an informed investment decision relating thereto, and (5) it is an &ldquo;Accredited Investor&rdquo; as defined in Rule 501(a)
of Regulation D under the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby represents and warrants that it is receiving the Shares for its own account and not with a view to the sale or distribution
of all or any part of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned understands that because the Shares have not been registered under the Act, it must continue to bear the economic risk of
the investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable federal
and state securities laws or an exemption from such registration is available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees that it shall in no event sell or distribute or otherwise dispose of all or any part of the Shares unless (1) there
is an effective registration statement under the Act and applicable state securities laws covering any such transaction involving the
Shares or (2) the Company receives an opinion of legal counsel to the undersigned (concurred in by legal counsel for the Company) stating
that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned consents to the placing of a legend on its certificate for the Shares stating that the Shares have not been registered and
setting forth the restriction on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company
and with any transfer agents against the Shares until the Shares may be legally resold or distributed without restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned has considered the Federal and state income and other tax implications of the exchange of the Warrant and the receipt and
subsequent sale of the Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Printed
    Name of Holder (Must conform in</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    respects to name of Holder as specified on the face of such Warrant)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Signatory (for an entity only)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of Signatory (for an entity only)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 245.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
10.3</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRECISION
HEALING INC.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020
STOCK OPTION AND GRANT PLAN</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6.2pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
1. <U>GENERAL PURPOSE OF THE PLAN; DEFINITIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
name of the Plan is the Precision Healing Inc. 2020 Stock Option and Grant Plan (the &ldquo;<B>Plan</B>&rdquo;). The purpose of the Plan
is to encourage and enable the officers, employees, directors, Consultants and other key Persons of Precision Healing Inc., a Delaware
corporation (including any successor entity, the &ldquo;<B>Company</B>&rdquo;) and its Subsidiaries, upon whose judgment, initiative
and efforts the Company largely depends for the successful conduct of its business, to acquire a proprietary interest in the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following terms shall be defined as set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Affiliate</B>&rdquo;
of any Person means a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under
common control with the first mentioned Person. A Person shall be deemed to control another Person if such first Person possesses directly
or indirectly the power to direct, or cause the direction of, the management and policies of the second Person, whether through the ownership
of voting securities, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Award</B>&rdquo;
or &ldquo;<B>Awards</B>,&rdquo; except where referring to a particular category of grant under the Plan, shall include Incentive Stock
Options, Non-Qualified Stock Options, early exercise Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards,
Restricted Stock Units or any combination of the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Award
Agreement</B>&rdquo; means a written or electronic agreement setting forth the terms and provisions applicable to an Award granted under
the Plan. Each Award Agreement may contain terms and conditions in addition to those set forth in the Plan; <I>provided, however</I>,
in the event of any conflict in the terms of the Plan and the Award Agreement, the terms of the Plan shall govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Board</B>&rdquo;
means the Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Cause</B>&rdquo;
shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not contain a definition of
&ldquo;<B>Cause</B>,&rdquo; it shall mean (i) the grantee&rsquo;s dishonest statements or acts with respect to the Company or any Affiliate
of the Company, or any current or prospective customers, suppliers vendors or other third parties with which such entity does business;
(ii) the grantee&rsquo;s commission of (A) a felony or (B) any misdemeanor involving moral turpitude, deceit, dishonesty or fraud; (iii)
the grantee&rsquo;s failure to perform his assigned duties and responsibilities to the reasonable satisfaction of the Company which failure
continues, in the reasonable judgment of the Company, after written notice given to the grantee by the Company; (iv) the grantee&rsquo;s
gross negligence, willful misconduct or insubordination with respect to the Company or any Affiliate of the Company; or (v) the grantee&rsquo;s
material violation of any provision of any agreement(s) between the grantee and the Company relating to noncompetition, nonsolicitation,
nondisclosure and/or assignment of inventions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 39pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Code</B>&rdquo;
means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 41.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Committee</B>&rdquo;
means the Committee of the Board referred to in Section 2.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Consultant</B>&rdquo;
means any natural person that provides bona fide services to the Company (including a Subsidiary), and such services are not in connection
with the offer or sale of securities in a capital-raising transaction and do not directly or indirectly promote or maintain a market
for the Company&rsquo;s securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 41.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Disability</B>&rdquo;
means &ldquo;disability&rdquo; as defined in Section 422(c) of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Effective
Date</B>&rdquo; means the date on which the Plan is adopted as set forth on the final page of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Exchange
Act</B>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Fair
Market Value</B>&rdquo; of the Stock on any given date means the fair market value of the Stock determined in good faith by the Committee
based on the reasonable application of a reasonable valuation method not inconsistent with Section 409A of the Code. If the Stock is
admitted to trade on a national securities exchange, the determination shall be made by reference to the closing price reported on such
exchange. If there is no closing price for such date, the determination shall be made by reference to the last date preceding such date
for which there is a closing price. If the date for which Fair Market Value is determined is the first day when trading prices for the
Stock are reported on a national securities exchange, the Fair Market Value shall be the &ldquo;Price to the Public&rdquo; (or equivalent)
set forth on the cover page for the final prospectus relating to the Company&rsquo;s Initial Public Offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Good
Reason</B>&rdquo; shall have the meaning as set forth in the Award Agreement(s). In the case that any Award Agreement does not
contain a definition of &ldquo;<B>Good Reason</B>,&rdquo; it shall mean (i) a material
diminution in the grantee&rsquo;s base salary except for across-the-board salary reductions similarly affecting all or substantially
all similarly situated employees of the Company or (ii) a change of more than fifty (50) miles in the geographic location at which
the grantee provides services to the Company, so long as the grantee provides at least ninety (90) days&rsquo; notice to the Company
following the initial occurrence of any such event and the Company fails to cure such event within thirty (30) days
thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Grant
Date</B>&rdquo; means the date that the Committee designates in its approval of an Award in accordance with applicable law as the date
on which the Award is granted, which date may not precede the date of such Committee approval.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Holder</B>&rdquo;
means, with respect to an Award or any Shares, the Person holding such Award or Shares, including the initial recipient of the Award
or any Permitted Transferee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Incentive
Stock Option</B>&rdquo; means any Stock Option designated and qualified as an &ldquo;incentive stock option&rdquo; as defined in Section
422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Initial
Public Offering</B>&rdquo; means the consummation of the first firm commitment underwritten public offering pursuant to an effective
registration statement under the Securities Act covering the offer and sale by the Company of its equity securities, as a result of or
following which the Stock shall be publicly held.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Non-Qualified
Stock Option</B>&rdquo; means any Stock Option that is not an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Option</B>&rdquo;
or &ldquo;<B>Stock Option</B>&rdquo; means any option to purchase shares of Stock granted pursuant to Section 5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Optionee</B>&rdquo;
means the &ldquo;Optionee&rdquo; as it is defined in the Award Agreement for the applicable Incentive Stock Option or Non-Qualified Stock
Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Permitted
Transferees</B>&rdquo; means any of the following to whom a Holder may transfer Shares hereunder (as set forth in Section 9(a)(ii)(A)):
the Holder&rsquo;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, any Person sharing the
Holder&rsquo;s household (other than a tenant or employee), a trust in which these Persons have more than fifty percent (50%) of the
beneficial interest, a foundation in which these Persons control the management of assets, and any other entity in which these Persons
own more than fifty percent (50%) of the voting interests; <I>provided, however</I>, that any such trust does not require or permit distribution
of any Shares during the term of the Award Agreement unless subject to its terms. Upon the death of the Holder, the term Permitted Transferees
shall also include such deceased Holder&rsquo;s estate, executors, administrators, personal representatives, heirs, legatees and distributees,
as the case may be.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Person</B>&rdquo;
means any individual, corporation, partnership (limited or general), limited liability company, limited liability partnership, association,
trust, joint venture, unincorporated organization or any similar entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Restricted
Stock Award</B>&rdquo; means Awards granted pursuant to Section 6 and &ldquo;<B>Restricted Stock</B>&rdquo; means Shares issued pursuant
to such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Restricted
Stock Unit</B>&rdquo; means an Award of phantom stock units to a grantee, which may be settled in cash or Shares as determined by the
Committee, pursuant to Section 8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Sale
Event</B>&rdquo; means the consummation of (i) the dissolution or liquidation of the Company, (ii) the sale of all or substantially all
of the assets of the Company on a consolidated basis to an unrelated Person or entity, (iii) a merger, reorganization or consolidation
pursuant to which the Holders of the Company&rsquo;s outstanding voting power immediately prior to such transaction do not own a majority
of the outstanding voting power of the surviving or resulting entity (or its ultimate parent, if applicable), (iv) the acquisition of
all or a majority of the outstanding voting stock of the Company in a single transaction or a series of related transactions by a Person
or group of Persons, or (v) any other acquisition of the business of the Company, as determined by the Board; <I>provided, however</I>,
that the Company&rsquo;s Initial Public Offering, any subsequent public offering or another capital raising event, or a merger effected
solely to change the Company&rsquo;s domicile shall not constitute a &ldquo;<B>Sale Event</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Section
409A</B>&rdquo; means Section 409A of the Code and the regulations and other guidance promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Securities
Act</B>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Service
Relationship</B>&rdquo; means any relationship as a full-time employee, part-time employee, director or other key Person (including Consultants)
of the Company or any Subsidiary or any successor entity (e.g., a Service Relationship shall be deemed to continue without interruption
in the event that an individual&rsquo;s status changes from full-time employee to part-time employee or Consultant).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Shares</B>&rdquo;
means shares of Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Stock</B>&rdquo;
means the Common Stock of the Company, $0.00001 par value per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Subsidiary</B>&rdquo; means any corporation or other
entity (other than the Company) in which the Company owns more than a fifty percent (50%) of the combined voting power of all
classes of stock thereof, either directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Ten
Percent Owner</B>&rdquo; means an employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the
Code) more than ten percent (10%) of the combined voting power of all classes of stock of the Company or any parent of the Company or
any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Termination
Event</B>&rdquo; means the termination of the Award recipient&rsquo;s Service Relationship with the Company and its Subsidiaries for
any reason whatsoever, regardless of the circumstances thereof, and including, without limitation, upon death, disability, retirement,
discharge or resignation for any reason, whether voluntarily or involuntarily. The following shall not constitute a Termination Event:
(i) a transfer to the service of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another
Subsidiary or (ii) an approved leave of absence for military service or sickness, or for any other purpose approved by the Committee,
if the individual&rsquo;s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which
the leave of absence was granted or if the Committee otherwise so provides in writing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B>Unrestricted
Stock Award</B>&rdquo; means any Award granted pursuant to Section 7 and &ldquo;<B>Unrestricted Stock</B>&rdquo; means Shares issued
pursuant to such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 2.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <U>ADMINISTRATION OF PLAN; COMMITTEE AUTHORITY TO SELECT
GRANTEES AND DETERMINE AWARDS</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Administration
of Plan</U>. The Plan shall be administered by the Board, or at the discretion of the Board, by a committee of the Board, comprised of
not less than two (2) directors. All references herein to the &ldquo;<B>Committee</B>&rdquo; shall be deemed to refer to the group then
responsible for administration of the Plan at the relevant time (i.e., either the Board or a committee or committees of the Board, as
applicable).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Powers
of Committee</U>. The Committee shall have the power and authority to grant Awards consistent with the terms of the Plan, including the
power and authority:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">to select the individuals to whom Awards may from time to time be granted;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
to determine the time or times of grant, and the amount, if any, of Incentive Stock Options, Non-Qualified Stock Options, Restricted
Stock Awards, Unrestricted Stock Awards, Restricted Stock Units, or any combination of the foregoing, granted to any one or more
grantees;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) to
determine the number of Shares to be covered by any Award and, subject to the provisions of the Plan, the price, exercise price, conversion
ratio or other price relating thereto;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) to
determine and, subject to Section 12, to modify from time to time the terms and conditions, including restrictions, not inconsistent
with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve
the form of Award Agreements;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
to accelerate at any time the exercisability or vesting of all or any portion of any Award;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
to impose any limitations on Awards, including limitations on transfers, repurchase provisions and the like, and to exercise
repurchase rights or obligations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii) subject
to Section 5(a)(ii) and any restrictions imposed by Section 409A, to extend at any time the period in which Stock Options may be exercised;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii) at
any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings
as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including Award Agreements); to make all
determinations it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and
to otherwise supervise the administration of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 5.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
decisions and interpretations of the Committee shall be binding on all Persons, including the Company and all Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Award
Agreement</U>. Awards under the Plan shall be evidenced by Award Agreements that set forth the terms, conditions and limitations for
each Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Indemnification</U>.
Neither the Board nor the Committee, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation,
construction or determination made in good faith in connection with the Plan, and the members of the Board and the Committee (and any
delegate thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage
or expense (including, without limitation, reasonable attorneys&rsquo; fees) arising or resulting therefrom to the fullest extent permitted
by law and/or under the Company&rsquo;s governing documents, including its certificate of incorporation or bylaws, or any directors&rsquo;
and officers&rsquo; liability insurance coverage which may be in effect from time to time and/or any indemnification agreement between
such individual and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Foreign
Award Recipients</U>. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries
in which the Company and any Subsidiary operate or have employees or other individuals eligible for Awards, the Committee, in its sole
discretion, shall have the power and authority to: (i) determine which Subsidiaries, if any, shall be covered by the Plan; (ii) determine
which individuals, if any, outside the United States are eligible to participate in the Plan; (iii) modify the terms and conditions of
any Award granted to individuals outside the United States to comply with applicable foreign laws; (iv) establish subplans and modify
exercise procedures and other terms and procedures, to the extent the Committee determines such actions to be necessary or advisable
(and such subplans and/or modifications shall be attached to the Plan as appendices); <I>provided, however</I>, that no such subplans
and/or modifications shall increase the share limitation contained in Section 3(a) hereof; and (v) take any action, before or after an
Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory
exemptions or approvals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 3.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <U>STOCK ISSUABLE UNDER THE PLAN; MERGERS AND OTHER TRANSACTIONS;
SUBSTITUTION</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Stock
Issuable</U>. The maximum number of Shares reserved and available for issuance under the Plan shall be 895,000 Shares, subject to adjustment
as provided in Section 3(b). For purposes of this limitation, the Shares underlying any Awards that are forfeited, canceled, reacquired
by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) and Shares
that are withheld upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding shall be added
back to the Shares available for issuance under the Plan. Subject to such overall limitations, Shares may be issued up to such maximum
number pursuant to any type or types of Award, and no more than 3,000,000 Shares may be issued pursuant to Incentive Stock Options. The
Shares available for issuance under the Plan may be authorized but unissued Shares or Shares reacquired by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Changes
in Stock</U>. Subject to Section 3(c) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend,
stock split, reverse stock split or other similar change in the Company&rsquo;s capital stock, the outstanding Shares are increased or
decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional Shares or new or
different shares or other securities of the Company or other non-cash assets are distributed with respect to such Shares or other securities,
in each case, without the receipt of consideration by the Company, or, if, as a result of any merger or consolidation, or sale of all
or substantially all of the assets of the Company, the outstanding Shares are converted into or exchanged for other securities of the
Company or any successor entity (or a parent or subsidiary thereof), the Committee shall make an appropriate and proportionate adjustment
in (i) the maximum number of Shares reserved for issuance under the Plan, (ii) the number and kind of Shares or other securities subject
to any then outstanding Awards under the Plan, (iii) the repurchase price, if any, per Share subject to each outstanding Award, and (iv)
the exercise price for each Share subject to any then outstanding Stock Options under the Plan, without changing the aggregate exercise
price (i.e., the exercise price multiplied by the number of Stock Options) as to which such Stock Options remain exercisable. The Committee
shall in any event make such adjustments as may be required by Section 25102(o) of the California Corporation Code and the rules and
regulations promulgated thereunder. The adjustment by the Committee shall be final, binding and conclusive. No fractional Shares shall
be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a cash payment in lieu of fractional
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Sale Events</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Options</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) In
the case of and subject to the consummation of a Sale Event, the Plan and all outstanding Options issued hereunder shall terminate upon
the effective time of any such Sale Event unless assumed or continued by the successor entity, or new stock options or other awards of
the successor entity or parent thereof are substituted therefor, with an equitable or proportionate adjustment as to the number and kind
of shares and, if appropriate, the per share exercise prices, as such parties shall agree (after taking into account any acceleration
hereunder and/or pursuant to the terms of any Award Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) In
the event of the termination of the Plan and all outstanding Options issued hereunder pursuant to Section 3(c), each Holder of Options
shall be permitted, within a period of time prior to the consummation of the Sale Event as specified by the Committee, to exercise all
such Options which are then exercisable or will become exercisable as of the effective time of the Sale Event; <I>provided, however</I>,
that the exercise of Options not exercisable prior to the Sale Event shall be subject to the consummation of the Sale Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C) Notwithstanding
anything to the contrary in Section 3(c)(i)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation,
to make or provide for a cash payment to the Holders of Options, without any consent of the Holders, in exchange for the cancellation
thereof, in an amount equal to the difference between (A) the value as determined by the Committee of the consideration payable per share
of Stock pursuant to the Sale Event (the &ldquo;<B>Sale Price</B>&rdquo;) times the number of Shares subject to outstanding Options being
cancelled (to the extent then vested and exercisable, including by reason of acceleration in connection with such Sale Event, at prices
not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding vested and exercisable Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restricted Stock and Restricted Stock Unit Awards</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 114pt; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) In
the case of and subject to the consummation of a Sale Event, all unvested Restricted Stock and unvested Restricted Stock Unit Awards
(other than those becoming vested as a result of the Sale Event) issued hereunder shall be forfeited immediately prior to the effective
time of any such Sale Event unless assumed or continued by the successor entity, or awards of the successor entity or parent thereof
are substituted therefor, with an equitable or proportionate adjustment as to the number and kind of shares subject to such awards as
such parties shall agree (after taking into account any acceleration hereunder and/or pursuant to the terms of any Award Agreement).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) In
the event of the forfeiture of Restricted Stock pursuant to Section 3(c)(ii)(A), such Restricted Stock shall be repurchased from the
Holder thereof at a price per share equal to the original per share purchase price paid by the Holder (subject to adjustment as provided
in Section 3(b)) for such Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C) Notwithstanding
anything to the contrary in Section 3(c)(ii)(A), in the event of a Sale Event, the Company shall have the right, but not the obligation,
to make or provide for a cash payment to the Holders of Restricted Stock or Restricted Stock Unit Awards, without consent of the Holders,
in exchange for the cancellation thereof, in an amount equal to the Sale Price times the number of Shares subject to such Awards, to
be paid at the time of such Sale Event or upon the later vesting of such Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
4. <U>ELIGIBILITY</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grantees
under the Plan will be such full or part-time officers and other employees, directors, Consultants and key Persons of the Company and
any Subsidiary who are selected from time to time by the Committee in its sole discretion; <I>provided, however</I>, that Awards shall
be granted only to those individuals described in Rule 701(c) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
5. <U>STOCK OPTIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the grant of a Stock Option, the Company and the grantee shall enter into an Award Agreement. The terms and conditions of each such Award
Agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards and grantees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
Options granted under the Plan may be either Incentive Stock Options or Non- Qualified Stock Options. Incentive Stock Options may be
granted only to employees of the Company or any Subsidiary that is a &ldquo;subsidiary corporation&rdquo; within the meaning of Section
424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock
Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Terms
of Stock Options</U>. The Committee in its discretion may grant Stock Options to those individuals who meet the eligibility requirements
of Section 4. Stock Options shall be subject to the following terms and conditions and shall contain such additional terms and conditions,
not inconsistent with the terms of the Plan, as the Committee shall deem desirable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Exercise
Price</U>. The exercise price per share for the Shares covered by a Stock Option shall be determined by the Committee at the time of
grant but shall not be less than one hundred percent (100%) of the Fair Market Value on the Grant Date. In the case of an Incentive Stock
Option that is granted to a Ten Percent Owner, the exercise price per share for the Shares covered by such Incentive Stock Option shall
not be less than one hundred ten percent (110%) of the Fair Market Value on the Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Option
Term</U>. The term of each Stock Option shall be fixed by the Committee, but no Stock Option shall be exercisable more than ten (10)
years from the Grant Date. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option
shall be no more than five (5) years from the Grant Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <U>Exercisability;
Rights of a Stockholder</U>. Stock Options shall become exercisable and/or vested at such time or times, whether or not in installments,
as shall be determined by the Committee at or after the Grant Date. The Award Agreement may permit a grantee to exercise all or a portion
of a Stock Option immediately at grant; <I>provided </I>that the Shares issued upon such exercise shall be subject to restrictions and
a vesting schedule identical to the vesting schedule of the related Stock Option, such Shares shall be deemed to be Restricted Stock
for purposes of the Plan, and the Optionee may be required to enter into an additional or new Award Agreement as a condition to exercise
of such Stock Option. An Optionee shall have the rights of a stockholder only as to Shares acquired upon the exercise of a Stock Option
and not as to unexercised Stock Options. An Optionee shall not be deemed to have acquired any Shares unless and until a Stock Option
shall have been exercised pursuant to the terms of the Award Agreement and this Plan and the Optionee&rsquo;s name has been entered on
the books of the Company as a stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) <U>Method
of Exercise</U>. Stock Options may be exercised by an Optionee in whole or in part, by the Optionee giving written or electronic notice
of exercise to the Company, specifying the number of Shares to be purchased. Payment of the purchase price may be made by one or more
of the following methods (or any combination thereof) to the extent provided in the Award Agreement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) In
cash, by certified or bank check, by wire transfer of immediately available funds, or other instrument acceptable to the Committee;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) If
permitted by the Committee, by the Optionee delivering to the Company a promissory note, if the Board has expressly authorized the loan
of funds to the Optionee for the purpose of enabling or assisting the Optionee to effect the exercise of his or her Stock Option; <I>provided
</I>that at least so much of the exercise price as represents the par value of the Stock shall be paid in cash if required by state law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C) If
permitted by the Committee and the Initial Public Offering has occurred (or the Stock otherwise becomes publicly-traded), through the
delivery (or attestation to the ownership) of Shares that have been purchased by the Optionee on the open market or that are beneficially
owned by the Optionee and are not then subject to restrictions under any Company plan. To the extent required to avoid variable accounting
treatment under ASC 718 or other applicable accounting rules, such surrendered Shares if originally purchased from the Company shall
have been owned by the Optionee for at least six (6) months. Such surrendered Shares shall be valued at Fair Market Value on the exercise
date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D) If
permitted by the Committee and the Initial Public Offering has occurred (or the Stock otherwise becomes publicly-traded), by the Optionee
delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver
to the Company cash or a check payable and acceptable to the Company for the purchase price; <I>provided </I>that in the event that the
Optionee chooses to pay the purchase price as so provided, the Optionee and the broker shall comply with such procedures and enter into
such agreements of indemnity and other agreements as the Committee shall prescribe as a condition of such payment procedure; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E) If
permitted by the Committee, and only with respect to Stock Options that are not Incentive Stock Options, by a &ldquo;net exercise&rdquo;
arrangement pursuant to which the Company will reduce the number of Shares issuable upon exercise by the largest whole number of Shares
with a Fair Market Value that does not exceed the aggregate exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
instruments will be received subject to collection. No certificates for Shares so purchased will be issued to the Optionee or, with
respect to uncertificated Stock, no transfer to the Optionee on the records of the Company will take place, until the Company has
completed all steps it has deemed necessary to satisfy legal requirements relating to the issuance and sale of the Shares, which
steps may include, without limitation, (i) receipt of a representation from the Optionee at the time of exercise of the Option that
the Optionee is purchasing the Shares for the Optionee&rsquo;s own account and not with a view to any sale or distribution of the
Shares or other representations relating to compliance with applicable law governing the issuance of securities, (ii) the legending
of the certificate (or notation on any book entry) representing the Shares to evidence the foregoing restrictions, and (iii)
obtaining from Optionee payment or provision for all withholding taxes due as a result of the exercise of the Option. The delivery
of certificates representing the shares of Stock (or the transfer to the Optionee on the records of the Company with respect to
uncertificated Stock) to be purchased pursuant to the exercise of a Stock Option will be contingent upon (A) receipt from the
Optionee (or a purchaser acting in his or her stead in accordance with the provisions of the Stock Option) by the Company of the
full purchase price for such Shares and the fulfillment of any other requirements contained in the Award Agreement or applicable
provisions of laws and (B) if required by the Company, the Optionee shall have entered into any stockholders agreements or other
agreements with the Company and/or certain other of the Company&rsquo;s stockholders relating to the Stock. In the event that an
Optionee chooses to pay the purchase price by previously-owned Shares through the attestation method, the number of Shares
transferred to the Optionee upon the exercise of the Stock Option shall be net of the number of Shares attested to.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Annual
Limit on Incentive Stock Options</U>. To the extent required for &ldquo;incentive stock option&rdquo; treatment under Section 422 of
the Code, the aggregate Fair Market Value (determined as of the Grant Date) of the Shares with respect to which Incentive Stock Options
granted under the Plan and any other plan of the Company or its parent and any Subsidiary that become exercisable for the first time
by an Optionee during any calendar year shall not exceed $100,000 or such other limit as may be in effect from time to time under Section
422 of the Code. To the extent that any Stock Option exceeds this limit, it shall constitute a Non-Qualified Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Termination</U>.
Any portion of a Stock Option that is not vested and exercisable on the date of termination of an Optionee&rsquo;s Service Relationship
shall immediately expire and be null and void. Once any portion of the Stock Option becomes vested and exercisable, the Optionee&rsquo;s
right to exercise such portion of the Stock Option (or the Optionee&rsquo;s representatives and legatees as applicable) in the event
of a termination of the Optionee&rsquo;s Service Relationship shall continue until the earliest of: (i) the date which is: (A) twelve
(12) months following the date on which the Optionee&rsquo;s Service Relationship terminates due to death or Disability (or such longer
period of time as determined by the Committee and set forth in the applicable Award Agreement), or (B) three (3) months following the
date on which the Optionee&rsquo;s Service Relationship terminates if the termination is due to any reason other than death or Disability
(or such longer period of time as determined by the Committee and set forth in the applicable Award Agreement), or (ii) the Expiration
Date set forth in the Award Agreement; <I>provided </I>that notwithstanding the foregoing, an Award Agreement may provide that if the
Optionee&rsquo;s Service Relationship is terminated for Cause, the Stock Option shall terminate immediately and be null and void upon
the date of the Optionee&rsquo;s termination and shall not thereafter be exercisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
6. <U>RESTRICTED STOCK AWARDS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Nature
of Restricted Stock Awards</U>. The Committee may, in its sole discretion, grant (or sell at par value or such other purchase price determined
by the Committee) to an eligible individual under Section 4 hereof a Restricted Stock Award under the Plan. The Committee shall determine
the restrictions and conditions applicable to each Restricted Stock Award at the time of grant. Conditions may be based on continuing
employment (or other Service Relationship), achievement of pre-established performance goals and objectives and/or such other criteria
as the Committee may determine. Upon the grant of a Restricted Stock Award, the Company and the grantee shall enter into an Award Agreement.
The terms and conditions of each such Award Agreement shall be determined by the Committee, and such terms and conditions may differ
among individual Awards and grantees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Rights
as a Stockholder</U>. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee of Restricted
Stock shall be considered the record owner of and shall be entitled to vote the Restricted Stock if, and to the extent, such Shares are
entitled to voting rights, subject to such conditions contained in the Award Agreement. The grantee shall be entitled to receive all
dividends and any other distributions declared on the Shares; <I>provided, however</I>, that the Company is under no duty to declare
any such dividends or to make any such distribution. Unless the Committee shall otherwise determine, certificates evidencing the Restricted
Stock shall remain in the possession of the Company until such Restricted Stock is vested as provided in subsection (d) below of this
Section, and the grantee shall be required, as a condition of the grant, to deliver to the Company a stock power endorsed in blank and
such other instruments of transfer as the Committee may prescribe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Restrictions</U>.
Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided
herein or in the Award Agreement. Except as may otherwise be provided by the Committee either in the Award Agreement or, subject to Section
12 below, in writing after the Award Agreement is issued, if a grantee&rsquo;s Service Relationship with the Company and any Subsidiary
terminates, the Company or its assigns shall have the right, as may be specified in the relevant instrument, to repurchase some or all
of the Shares subject to the Award at such purchase price as is set forth in the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Vesting
of Restricted Stock</U>. The Committee at the time of grant shall specify in the Award Agreement the date or dates and/or the attainment
of pre-established performance goals, objectives and other conditions on which the substantial risk of forfeiture imposed shall lapse
and the Restricted Stock shall become vested, subject to such further rights of the Company or its assigns as may be specified in the
Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
7. <U>UNRESTRICTED STOCK AWARDS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Committee may, in its sole discretion, grant (or sell at par value or such other purchase price determined by the Committee) to an eligible
Person under Section 4 hereof an Unrestricted Stock Award under the Plan. Unrestricted Stock Awards may be granted in respect of past
services or other valid consideration, or in lieu of cash compensation due to such grantee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
8. <U>RESTRICTED STOCK UNITS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Nature
of Restricted Stock Units</U>. The Committee may, in its sole discretion, grant to an eligible Person under Section 4 hereof Restricted
Stock Units under the Plan. The Committee shall determine the restrictions and conditions applicable to each Restricted Stock Unit at
the time of grant. Vesting conditions may be based on continuing employment (or other Service Relationship), achievement of pre-established
performance goals and objectives and/or other such criteria as the Committee may determine. Upon the grant of Restricted Stock Units,
the grantee and the Company shall enter into an Award Agreement. The terms and conditions of each such Award Agreement shall be determined
by the Committee and may differ among individual Awards and grantees. On or promptly following the vesting date or dates applicable to
any Restricted Stock Unit, but in no event later than March 15 of the year following the year in which such vesting occurs, such Restricted
Stock Unit(s) shall be settled in the form of cash or shares of Stock, as specified in the Award Agreement. Restricted Stock Units may
not be sold, assigned, transferred, pledged, or otherwise encumbered or disposed of.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Rights
as a Stockholder</U>. A grantee shall have the rights of a stockholder only as to Shares, if any, acquired upon settlement of Restricted
Stock Units. A grantee shall not be deemed to have acquired any such Shares unless and until the Restricted Stock Units shall have been
settled in Shares pursuant to the terms of the Plan and the Award Agreement, the Company shall have issued and delivered a certificate
representing the Shares to the grantee (or transferred on the records of the Company with respect to uncertificated stock), and the grantee&rsquo;s
name has been entered in the books of the Company as a stockholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>Termination</U>.
Except as may otherwise be provided by the Committee either in the Award Agreement or in writing after the Award Agreement is issued,
a grantee&rsquo;s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee&rsquo;s cessation
of Service Relationship with the Company and any Subsidiary for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION 9.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <U>TRANSFER RESTRICTIONS; COMPANY RIGHT OF FIRST REFUSAL;
COMPANY REPURCHASE RIGHTS</U></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Restrictions on Transfer</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Non-Transferability
of Stock Options</U>. Stock Options and, prior to exercise, the Shares issuable upon exercise of such Stock Option, shall not be transferable
by the Optionee otherwise than by will, or by the laws of descent and distribution, and all Stock Options shall be exercisable, during
the Optionee&rsquo;s lifetime, only by the Optionee, or by the Optionee&rsquo;s legal representative or guardian in the event of the
Optionee&rsquo;s incapacity. Notwithstanding the foregoing, the Committee, in its sole discretion, may provide in the Award Agreement
regarding a given Stock Option that the Optionee may transfer by gift, without consideration for the transfer, his or her Non-Qualified
Stock Options to his or her family members (as defined in Rule 701 of the Securities Act), to trusts for the benefit of such family members,
or to partnerships in which such family members are the only partners (to the extent such trusts or partnerships are considered &ldquo;family
members&rdquo; for purposes of Rule 701 of the Securities Act), <I>provided </I>that the transferee agrees in writing with the Company
to be bound by all of the terms and conditions of this Plan and the applicable Award Agreement, including the execution of a stock power
upon the issuance of Shares. Stock Options, and the Shares issuable upon exercise of such Stock Options, shall be restricted as to any
pledge, hypothecation, or other transfer, including any short position, any &ldquo;put equivalent position&rdquo; (as defined in the
Exchange Act) or any &ldquo;call equivalent position&rdquo; (as defined in the Exchange Act) prior to exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Shares</U>.
No Shares shall be sold, assigned, transferred, pledged, hypothecated, given away or in any other manner disposed of or encumbered,
whether voluntarily or by operation of law, unless (i) the transfer is in compliance with the terms of the applicable Award
Agreement, all applicable securities laws (including, without limitation, the Securities Act), and with the terms and conditions of
this Section 9, (ii) the transfer does not cause the Company to become subject to the reporting requirements of the Exchange Act,
and (iii) the transferee consents in writing to be bound by the provisions of the Plan and the Award Agreement, including this
Section 9. In connection with any proposed transfer, the Committee may require the transferor to provide at the transferor&rsquo;s
own expense an opinion of counsel to the transferor, satisfactory to the Committee, that such transfer is in compliance with all
foreign, federal and state securities laws (including, without limitation, the Securities Act). Any attempted transfer of Shares not
in accordance with the terms and conditions of this Section 9 shall be null and void, and the Company shall not reflect on its
records any change in record ownership of any Shares as a result of any such transfer, shall otherwise refuse to recognize any such
transfer and shall not in any way give effect to any such transfer of Shares. The Company shall be entitled to seek protective
orders, injunctive relief and other remedies available at law or in equity including, without limitation, seeking specific
performance or the rescission of any transfer not made in strict compliance with the provisions of this Section 9. Subject to the
foregoing general provisions, and unless otherwise provided in the applicable Award Agreement, Shares may be transferred pursuant to
the following specific terms and conditions (<I>provided</I> that with respect to any transfer of Restricted Stock, all vesting and
forfeiture provisions shall continue to apply with respect to the original recipient):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) <U>Transfers
to Permitted Transferees</U>. The Holder may transfer any or all of the Shares to one or more Permitted Transferees; <I>provided, however</I>,
that following such transfer, such Shares shall continue to be subject to the terms of this Plan (including this Section 9) and such
Permitted Transferee(s) shall, as a condition to any such transfer, deliver a written acknowledgment to that effect to the Company and
shall deliver a stock power to the Company with respect to the Shares. Notwithstanding the foregoing, the Holder may not transfer any
of the Shares to a Person whom the Company reasonably determines is a direct competitor or a potential competitor of the Company or any
of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 42pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) <U>Transfers
Upon Death</U>. Upon the death of the Holder, any Shares then held by the Holder at the time of such death and any Shares acquired after
the Holder&rsquo;s death by the Holder&rsquo;s legal representative shall be subject to the provisions of this Plan, and the Holder&rsquo;s
estate, executors, administrators, personal representatives, heirs, legatees and distributees shall be obligated to convey such Shares
to the Company or its assigns under the terms contemplated by the Plan and the Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Right
of First Refusal</U>. In the event that a Holder desires at any time to sell or otherwise transfer all or any part of his or her Shares
(other than shares of Restricted Stock which by their terms are not transferrable), the Holder first shall give written notice to the
Company of the Holder&rsquo;s intention to make such transfer. Such notice shall state the number of Shares that the Holder proposes
to sell (the &ldquo;<B>Offered Shares</B>&rdquo;), the price and the terms at which the proposed sale is to be made and the name and
address of the proposed transferee. At any time within thirty (30) days after the receipt of such notice by the Company, the Company
or its assigns may elect to purchase all or any portion of the Offered Shares at the price and on the terms offered by the proposed transferee
and specified in the notice. The Company or its assigns shall exercise this right by mailing or delivering written notice to the Holder
within the foregoing thirty-day (30) period. If the Company or its assigns elect to exercise its purchase rights under this Section 9(b),
the closing for such purchase shall, in any event, take place within forty-five (45) days after the receipt by the Company of the initial
notice from the Holder. In the event that the Company or its assigns do not elect to exercise such purchase right, or in the event that
the Company or its assigns do not pay the full purchase price within such forty-five-day (45) period, the Holder shall be required to
pay a transaction processing fee of $10,000 to the Company (unless waived by the Committee) and then may, within sixty (60) days thereafter,
sell the Offered Shares to the proposed transferee and at the same price and on the same terms as specified in the Holder&rsquo;s notice.
Any Shares not sold to the proposed transferee shall remain subject to the Plan. If the Holder is a party to any stockholders agreements
or other agreements with the Company and/or certain other of the Company&rsquo;s stockholders relating to the Shares, (i) the transferring
Holder shall comply with the requirements of such stockholders agreements or other agreements relating to any proposed transfer of the
Offered Shares, and (ii) any proposed transferee that purchases Offered Shares shall enter into such stockholders agreements or other
agreements with the Company and/or certain of the Company&rsquo;s stockholders relating to the Offered Shares on the same terms and in
the same capacity as the transferring Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Company&rsquo;s Right of Repurchase</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Right
of Repurchase for Unvested Shares Issued Upon the Exercise of an Option</U>. Upon a Termination Event, the Company or its assigns shall
have the right and option to repurchase from a Holder of Shares acquired upon exercise of a Stock Option which are still subject to a
risk of forfeiture as of the Termination Event. Such repurchase rights may be exercised by the Company within the later of (A) six (6)
months following the date of such Termination Event or (B) seven (7) months after the acquisition of Shares upon exercise of a Stock
Option. The repurchase price shall be equal to the lower of the original per share price paid by the Holder, subject to adjustment as
provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its
repurchase rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Right
of Repurchase With Respect to Restricted Stock</U>. Upon a Termination Event, the Company or its assigns shall have the right and option
to repurchase from a Holder of Shares received pursuant to a Restricted Stock Award any Shares that are still subject to a risk of forfeiture
as of the Termination Event. Such repurchase right may be exercised by the Company within six (6) months following the date of such Termination
Event. The repurchase price shall be the lower of the original per share purchase price paid by the Holder, subject to adjustment as
provided in Section 3(b) of the Plan, or the current Fair Market Value of such Shares as of the date the Company elects to exercise its
repurchase rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) <U>Procedure</U>.
Any repurchase right of the Company shall be exercised by the Company or its assigns by giving the Holder written notice on or before
the last day of the repurchase period of its intention to exercise such repurchase right. Upon such notification, the Holder shall promptly
surrender to the Company, free and clear of any liens or encumbrances, any certificates representing the Shares being purchased, together
with a duly executed stock power for the transfer of such Shares to the Company or the Company&rsquo;s assignee or assignees. Upon the
Company&rsquo;s or its assignee&rsquo;s receipt of the certificates from the Holder, the Company or its assignee or assignees shall deliver
to him, her or them a check for the applicable repurchase price; <I>provided, however</I>, that the Company may pay the repurchase price
by offsetting and canceling any indebtedness then owed by the Holder to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Drag Along Right</U>. In the event the holders of a majority of the Company&rsquo;s equity securities then outstanding (the &ldquo;<B>Majority
Shareholders</B>&rdquo;) determine to enter into a Sale Event in a bona fide negotiated transaction (a &ldquo;<B>Sale</B>&rdquo;), with
any non-Affiliate of the Company or any majority shareholder (in each case, the &ldquo;<B>Buyer</B>&rdquo;), a Holder of Shares, including
any Permitted Transferee, shall be obligated to and shall upon the written request of the Majority Shareholders: (a)&#9;sell, transfer
and deliver, or cause to be sold, transferred and delivered, to the Buyer, his or her Shares (including for this purpose all of such
Holder&rsquo;s Shares that presently or as a result of any such transaction may be acquired upon the exercise of an Option (following
the payment of the exercise price therefor)) on substantially the same terms applicable to the Majority Shareholders (with appropriate
adjustments to reflect the conversion of convertible securities, the redemption of redeemable securities and the exercise of exercisable
securities as well as the relative preferences and priorities of preferred stock); and (b) execute and deliver such instruments of conveyance
and transfer and take such other action, including voting such Shares in favor of any Sale proposed by the Majority Shareholders and
executing any purchase agreements, merger agreements, indemnity agreements, escrow agreements or related documents as the Majority Shareholders
or the Buyer may reasonably require in order to carry out the terms and provisions of this Section 9(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Escrow Arrangement</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) <U>Escrow</U>.
In order to carry out the provisions of this Section 9 of this Plan more effectively, the Company shall hold any Shares issued pursuant
to Awards granted under the Plan in escrow together with separate stock powers executed by the Holder in blank for transfer. The Company
shall not dispose of the Shares except as otherwise provided in this Plan. In the event of any repurchase by the Company (or any of its
assigns), the Company is hereby authorized by the Holder, as the Holder&rsquo;s attorney-in-fact, to date and complete the stock powers
necessary for the transfer of the Shares being purchased and to transfer such Shares in accordance with the terms hereof. At such time
as any Shares are no longer subject to the Company&rsquo;s repurchase and first refusal rights, the Company shall, at the written request
of the Holder, deliver to the Holder a certificate representing such Shares with the balance of the Shares to be held in escrow pursuant
to this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <U>Remedy</U>.
Without limitation of any other provision of this Plan or other rights, in the event that a Holder or any other Person is required to
sell a Holder&rsquo;s Shares pursuant to the provisions of Sections 9(b) or (c) hereof and in the further event that he or she refuses
or for any reason fails to deliver to the Company or its designated purchaser of such Shares the certificate or certificates evidencing
such Shares together with a related stock power, the Company or such designated purchaser may deposit the applicable purchase price for
such Shares with a bank designated by the Company, or with the Company&rsquo;s independent public accounting firm, as agent or trustee,
or in escrow, for such Holder or other Person, to be held by such bank or accounting firm for the benefit of and for delivery to him,
her, them or it, and/or, in its discretion, pay such purchase price by offsetting any indebtedness then owed by such Holder as provided
above. Upon any such deposit and/or offset by the Company or its designated purchaser of such amount and upon notice to the Person who
was required to sell the Shares to be sold pursuant to the provisions of Sections 9(b) or (c), such Shares shall at such time be deemed
to have been sold, assigned, transferred and conveyed to such purchaser, such Holder shall have no further rights thereto (other than
the right to withdraw the payment thereof held in escrow, if applicable), and the Company shall record such transfer in its stock transfer
book or in any appropriate manner.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Lockup
Provision</U>. If requested by the Company, a Holder shall not sell or otherwise transfer or dispose of any Shares (including, without
limitation, pursuant to Rule 144 under the Securities Act) held by him or her for such period following the effective date of a public
offering by the Company of Shares as the Company shall specify reasonably and in good faith. If requested by the underwriter engaged
by the Company, each Holder shall execute a separate letter confirming his or her agreement to comply with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Adjustments
for Changes in Capital Structure</U>. If, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock
split, reverse stock split or other similar change in the Stock, the outstanding Shares are increased or decreased or are exchanged for
a different number or kind of securities of the Company, the restrictions contained in this Section 9 shall apply with equal force to
additional and/or substitute securities, if any, received by Holder in exchange for, or by virtue of his or her ownership of, Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) <U>Termination</U>.
The terms and provisions of Section 9(b) and Section 9(c) (except for the Company&rsquo;s right to repurchase Shares still subject to
a risk of forfeiture upon a Termination Event) shall terminate upon the closing of the Company&rsquo;s Initial Public Offering or upon
consummation of any Sale Event, in either case as a result of which Shares are registered under Section 12 of the Exchange Act and publicly-traded
on any national security exchange.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
10. <U>TAX WITHHOLDING</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>Payment
by Grantee</U>. Each grantee shall, no later than the date as of which the value of an Award or of any Shares or other amounts received
thereunder first becomes includable in the gross income of the grantee for income tax purposes, pay to the Company, or make arrangements
satisfactory to the Committee regarding payment of, any Federal, state, or local taxes of any kind required by law to be withheld by
the Company with respect to such income. The Company and any Subsidiary shall, to the extent permitted by law, have the right to deduct
any such taxes from any payment of any kind otherwise due to the grantee. The Company&rsquo;s obligation to deliver stock certificates
(or evidence of book entry) to any grantee is subject to and conditioned on any such tax withholding obligations being satisfied by the
grantee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Payment
in Stock</U>. The Company&rsquo;s minimum required tax withholding obligation may be satisfied, in whole or in part, by the Company withholding
from Shares to be issued pursuant to an Award a number of Shares having an aggregate Fair Market Value (as of the date the withholding
is effected) that would satisfy the minimum withholding amount due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
11. <U>SECTION 409A AWARDS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent that any Award is determined to constitute &ldquo;nonqualified deferred compensation&rdquo; within the meaning of Section
409A (a &ldquo;<B>409A Award</B>&rdquo;), the Award shall be subject to such additional rules and requirements as may be specified by
the Committee from time to time. In this regard, if any amount under a 409A Award is payable upon a &ldquo;separation from service&rdquo;
(within the meaning of Section 409A) to a grantee who is considered a &ldquo;specified employee&rdquo; (within the meaning of Section
409A), then no such payment shall be made prior to the date that is the earlier of (i) six (6) months and one (1) day after the grantee&rsquo;s
separation from service, or (ii) the grantee&rsquo;s death, but only to the extent such delay is necessary to prevent such payment from
being subject to interest, penalties and/or additional tax imposed pursuant to Section 409A. The Company makes no representation or warranty
and shall have no liability to any grantee under the Plan or any other Person with respect to any penalties or taxes under Section 409A
that are, or may be, imposed with respect to any Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
12. <U>AMENDMENTS AND TERMINATION</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may, at any time, amend or discontinue the Plan and the Committee may, at any time, amend or cancel any outstanding Award for the
purpose of satisfying changes in law or for any other lawful purpose, but no such action shall adversely affect rights under any outstanding
Award without the consent of the Holder of the Award. The Committee may exercise its discretion to reduce the exercise price of outstanding
Stock Options or effect repricing through cancellation of outstanding Stock Options and by granting such Holders new Awards in replacement
of the cancelled Stock Options. To the extent determined by the Committee to be required either by the Code to ensure that Incentive
Stock Options granted under the Plan are qualified under Section 422 of the Code or otherwise, Plan amendments shall be subject to approval
by the Company stockholders entitled to vote at a meeting of stockholders. Nothing in this Section 12 shall limit the Board&rsquo;s or
Committee&rsquo;s authority to take any action permitted pursuant to Section 3(c). The Board reserves the right to amend the Plan and/or
the terms of any outstanding Stock Options to the extent reasonably necessary to comply with the requirements of the exemption pursuant
to paragraph (f)(4) of Rule 12h-1 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
13. <U>STATUS OF PLAN</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by
a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Committee shall otherwise
expressly so determine in connection with any Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
14. <U>GENERAL PROVISIONS</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) <U>No
Distribution; Compliance with Legal Requirements</U>. The Committee may require each Person acquiring Shares pursuant to an Award to
represent to and agree with the Company in writing that such Person is acquiring the Shares without a view to distribution thereof. No
Shares shall be issued pursuant to an Award until all applicable securities law and other legal and stock exchange or similar requirements
have been satisfied. The Committee may require the placing of such stop-orders and restrictive legends on certificates for Stock and
Awards as it deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) <U>Delivery
of Stock Certificates</U>. Stock certificates to grantees under the Plan shall be deemed delivered for all purposes when the Company
or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at
the grantee&rsquo;s last known address on file with the Company; <I>provided </I>that stock certificates to be held in escrow pursuant
to Section 9 of the Plan shall be deemed delivered when the Company shall have recorded the issuance in its records. Uncertificated Stock
shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have given to the grantee
by electronic mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee&rsquo;s last known address
on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic &ldquo;book entry&rdquo;
records).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) <U>No
Employment Rights</U>. The adoption of the Plan and the grant of Awards do not confer upon any Person any right to continued employment
or Service Relationship with the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) <U>Trading
Policy Restrictions</U>. Option exercises and other Awards under the Plan shall be subject to the Company&rsquo;s insider trading policy-related
restrictions, terms and conditions as may be established by the Committee, or in accordance with policies set by the Committee, from
time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) <U>Designation
of Beneficiary</U>. Each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise
any Award on or after the grantee&rsquo;s death or receive any payment under any Award payable on or after the grantee&rsquo;s death.
Any such designation shall be on a form provided for that purpose by the Committee and shall not be effective until received by the Committee.
If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary
shall be the grantee&rsquo;s estate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) <U>Legend</U>.
Any certificate(s) representing the Shares shall carry substantially the following legend (and with respect to uncertificated Stock,
the book entries evidencing such Shares shall contain the following notation):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75in 0pt 0.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transferability of this certificate and the shares of stock represented hereby are subject to the restrictions, terms and conditions
(including repurchase and restrictions against transfers) contained in the Precision Healing Inc. 2020 Stock Option and Grant Plan and
any agreements entered into thereunder by and between the Company and the holder of this certificate (a copy of which is available at
the offices of the Company for examination).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.95pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) <U>Information
to Holders of Options</U>. In the event that the Company is relying on the exemption from the registration requirements of Section 12(g)
of the Exchange Act contained in paragraph (f)(1) of Rule 12h-1 of the Exchange Act, the Company shall provide the information described
in Rule 701(e)(3), (4) and (5) of the Securities Act to all Holders of Options in accordance with the requirements thereunder. The foregoing
notwithstanding, the Company shall not be required to provide such information unless the optionholder has agreed in writing, on a form
prescribed by the Company, to keep such information confidential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
15. <U>EFFECTIVE DATE OF PLAN</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall become effective upon adoption by the Board and shall be approved by stockholders in accordance with applicable state law
and the Company&rsquo;s articles of incorporation and bylaws within twelve (12) months thereafter. If the stockholders fail to approve
the Plan within twelve (12) months after its adoption by the Board, then any Awards granted or sold under the Plan shall be rescinded
and no additional grants or sales shall thereafter be made under the Plan. Subject to such approval by stockholders and to the requirement
that no Shares may be issued hereunder prior to such approval, Stock Options and other Awards may be granted hereunder on and after adoption
of the Plan by the Board. No grants of Stock Options and other Awards may be made hereunder after the tenth (10<SUP>th</SUP>) anniversary
of the date the Plan is adopted by the Board or the date the Plan is approved by the Company&rsquo;s stockholders, whichever is earlier.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECTION
16. <U>GOVERNING LAW</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Plan, all Awards and any controversy arising out of or relating to this Plan and all Awards shall be governed by and construed in accordance
with the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be
governed by and construed in accordance with the internal laws of the State of Delaware, without regard to conflict of law principles
that would result in the application of any law other than the law of the State of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATE
ADOPTED BY THE BOARD:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DATE
APPROVED BY THE STOCKHOLDERS:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 6pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 57.75pt; width: 172.5pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Sanara
MedTech Inc. Announces Closing of Merger to Acquire Precision Healing Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>FORT
WORTH, TX / April 4, 2022 / Sanara MedTech Inc</B>. (&ldquo;Sanara,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo;
or &ldquo;us&rdquo;) (NASDAQ: SMTI), a provider of products and technologies for surgical and chronic wound care dedicated to improving
patient outcomes, announced today that it has closed the previously announced merger to acquire Precision Healing Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">With
a focus on improving patient outcomes through evidence-based healing solutions, Sanara MedTech Inc. markets, distributes and develops
wound and skincare products for use by physicians and clinicians in hospitals, clinics, and all post-acute care settings and offers wound
care and dermatology virtual consultation services via telemedicine. Sanara&rsquo;s products are primarily sold in the North American
advanced wound care and surgical tissue repair markets. Sanara MedTech markets and distributes CellerateRX<SUP>&reg;</SUP> Surgical Activated
Collagen<SUP>&reg;</SUP>, FORTIFY TRG<SUP>&trade;</SUP> Tissue Repair Graft and FORTIFY FLOWABLE<SUP>&trade;</SUP> Extracellular Matrix
to the surgical markets as well as the following products to the wound care market: BIAK&Omacr;S<SUP>&trade;</SUP> Antimicrobial Skin
and Wound Cleanser, BIAK&Omacr;S<SUP>&trade;</SUP> Antimicrobial Wound Gel, BIAK&Omacr;S<SUP>&trade;</SUP> Antimicrobial Skin and Wound
Irrigation Solution and HYCOL<SUP>&trade;</SUP> Hydrolyzed Collagen. Sanara&rsquo;s pipeline also contains potentially transformative
product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic tissue debridement,
and cell compatible substrates. The Company believes it has acquired the ability to drive its pipeline from concept to preclinical and
clinical development while meeting quality and regulatory requirements. Sanara is constantly seeking long-term strategic partnerships
with a focus on products that improve outcomes at a lower overall cost. In addition, Sanara is actively seeking to expand within its
six focus areas of wound and skincare for the acute, post-acute, and surgical markets. The focus areas are debridement, biofilm removal,
hydrolyzed collagen, advanced biologics, negative pressure wound therapy adjunct products, and the oxygen delivery system segment of
the healthcare industry.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Information
about Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
statements in this press release that do not constitute historical facts are &ldquo;forward-looking statements,&rdquo; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &ldquo;aim,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believe,&rdquo; contemplate,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo;
&ldquo;preliminary,&rdquo; &ldquo;project,&rdquo; &ldquo;seek,&rdquo; &ldquo;target,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo;
or &ldquo;would, or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements
include statements regarding, the development of new products, and expansion of the Company&rsquo;s business in telehealth and wound
care. These items involve risks, contingencies and uncertainties such as our ability to satisfy the closing conditions for and consummate
the merger on the expected timeline or at all, the ability to integrate and retain key personnel from Precision Healing, uncertainties
associated with the development and process for obtaining regulatory approval for new products, the extent of product demand, market
and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions,
and other risks, contingencies and uncertainties detailed in the Company&rsquo;s SEC filings, which could cause the Company&rsquo;s actual
operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investor
Contact:</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Callon
Nichols, Director of Investor Relations</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">713-826-0524</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>CNichols@sanaramedtech.com</U></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>SOURCE:
Sanara MedTech Inc</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "P @X# 2(  A$! Q$!_\0
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M&.0_1<9;US]IWXW_  +_ &6_A3JO[3?Q\N+:RT?P?:-*VJ'3Q/<Q&1EC$,
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MHR/6@ HHS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGACX&SSQ^*KWP[-%HQM;CR9GD.-R1OD;'9-RJV1AF'(K\I/^"37A+XT?L_\
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M.H0VEG:0--=75S*$CAC499V8\*H ))/ %>1F^3XS)<=]5Q%G*R?NNZUV^?\
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M$X"@!\DD\ #K724G&4=T"E&6S"BLOQ'XY\$^#WBC\6^,-+TMIP3 NI:A' 9
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MYV5/SZ_9$_X+H?"+]C#]HG4O$_P"_P""=O@'PEX#UW4/)U:/2[J]G\0?V>9
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MY+A<CX;IT<FRVDX4W&4XV4I0M>[O-MZMRNKO;;H>T4445XY]*%%%% !7X/\
M_!W)8^)$_:-^$>I73M_8\O@J]BL5W<"Y6[S.<=OD>W^N/:OW@KXH_P""X_\
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MQ7Y;_P#!;7_@O8/V/=9O_P!E/]D2>ROOB.L!3Q%XFF5+BV\-%E^6.-,E9;P
M[BK@I%\NY7)*K]D?\%1/VR+?]A#]B/QM^T+;S1C6K.Q%EX5ADB$@FU6X/E6_
MRGAE1B96!_@B?KT/\N'P;^%/Q@_;0_:1T;X5^$9I=:\9^/O$7E?;+^9F,MQ,
MY>:YF?D[5&^61L$A58X-?2<-911Q7-BL3_#AT>S:U;?DE]Y\YQ)F];"\N%PW
M\2?5;I/16\V_ZU(O%'B[]I+]L;XNMJ_B?5O%OQ(\;:W)A2WGZE?7&!]Q$4,V
MU5Z*H"JHX  KZ"\#_P#!!C_@K7\1/#R>)-"_8WU:VMY.8X==U_2],N#TX,%Y
M=12KP?XE'0]^*_H)_P""='_!,_\ 9W_X)Q_".W\$_"SP[;WGB2ZM57Q3XUN[
M9?MVK3<%@7QF. ,!LA4[5 !.YMS'Z+V@\8KLQ?&$J<^3!TURK1-WU]$FK''A
M>#X5(\^,J/F>K2MI\W>Y_)+JWPI_X*)?\$SOB+9_$;4_ _Q$^%.M6<X2SUY;
M2>VAE)_Y9B=<PSHV,%-SJPR"",BOUJ_8$_X+H6'[=G[)OQ)_9I_:7:STOXK6
MOPOUQM+U"UB\JV\40Q:;*9'"CY8;H ,[QKA' 9D"@%%_5KQOX$\%?$KPE?>
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MV@WL5K'.H31RA6:"UB16GD!=]SW!15!6)0%(R_SY^SK_ ,&SOPY_:0\1Z?\
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M3GX'X_Z!.N_^C;.G_P#!HI\*] U'Q9\:OC5?6^[4],L-'T739,C]W#</=3W
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MX+?MB7W_  4<U634-)UBUU>;7IH=6\1)#HMCJ$I8O>8=05.^0N%:38KD84
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M\:S^'9^C_P M_D>7G&7_ -IX&5%?%NO5?Y[?,_*/_@V)_P""G?A#PUX?N/\
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M37PCT3XW_!+Q?:ZYX<UZT6XL;ZV;I_>C=>L<B-E71L,K @C(KM!7\CO[%_\
MP48_:X_8#\3R:_\ LV?%2XTVSNI=^J>';U!<Z9?M@#=+;O\ +OPH'F+MD &
MP'%?>_A+_@[:_:HT_1&M/&O[+O@/5+\1[8[W3]0O+2/=_>:-FES] RUEC.$<
M?3JOZNU*/36S^=]/N-L'Q=@*E)?6+PEUT;7RMK]Y^]9Z5^(__!R[_P %5O _
MC;0F_P"">7P$\26^J"#5([GXF:M9R;X8Y(&W0Z:C@X9ED DEQ]UHXTSD2*/E
M/]K+_@XI_P""C/[4OA>Z\!:9XMTGX=Z+>96ZA\!VLMO=3Q_W#=2R23(/7RVC
MSD@Y!Q7IW_!-#_@ASX_\2_ _QM^W'^V5X+N-)T+1_ 6KZCX%\)ZQ"4NM5NA8
M220ZA.A.Z.!#\Z(X#2N%8CRP/,ZLOR6GDTEB\?)73]V*UN^GJ_3;=LY<=G53
M.(O"8"+L_BD]++K\GY[[)'PO^PU_R>K\'N/^:I>'_P#TY05_7]7\@/[#7_)Z
MOP?_ .RI>'__ $Y05_7]4\:_QZ/H_P T'!?^[UO5?DS\0?\ @[Q_Y'GX'?\
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M9?\ (LA_C7Y2/W#_ .""7_*(_P"#/_8)U'_TZWE?7U?(/_!!(_\ &H_X,_\
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M)?CK_P %#/%VC?LC_M;_  FN)/%WB:[U*Z\*:[X@EM;[1[J>5IKBV58X9$N
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M#QIK?G79L-0/GRS6V]FS+%&(XLQY)1;UL=4 ]J_94_;L_80_X+;?!;QEK/\
MP40_99\-V_B3X,Z'-KU]-:23L'T@(6FGM9499XP'3:]N7926B8%B<+\^?LZ?
M\',/PW_9M\1:?\(/A%^P+X=\'_!JUU0JEAH&IO\ VM#;O)\]VQ8>7/<;/F*L
M?F("F7&&K[B*QTLN6#H8>U6DXMOW;)K6Z=]7);KS=SXF4L#','C*^(O2K*22
M]Z[3T::MHD]GY(SO^">O_!$S3?@=_P %$_"]A^UQ^UM\*UNO!/B*#4K#PAX8
M\22W-]JVH6\@EMH6\V"-(5,BQNT;'S74; @W;E_1+_@N?\#OVC/C;\ O#*_
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M[3_97_8:_90_8I\,-X5_9F^"FC^&(YEQ>7UO&9KV\Y!_?74I::49&0K.57L
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MT_6M/N)KO4;57VK+-,LR>6[*-P5% 3?@[\9KZ*_X*2_L+_#7_@M3^R[\+_\
M@I5\-_C)X>^&.K-X-BMKY_B!>_9]-:T\^5C;2W/2%X;I[A5?:5D$G.WBO#?!
M'_!#C]@;_@I5\;_$'Q>_8!_X*"67_"!?VPEUKW@__A$Y_P"U-$69F9HHQ<-
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M8ZIGTK^VS^WE\*/^"9OPV\(^$H?A_?:_>7=E]B\.Z':WBVZ):VB1QEI)BK;
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M XQAACYE7(S\@?$'Q1X?\$_\%O%\8>*]5AL=,TNRDNM0O+AL)#"GA^5F<^P
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MTEO*[[]?C\1P/E.;87%XNMFDI4<7)2IM?#%J3:WDU)13<;6C9*VG2#_@@?\
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M-Q=0<[%-=%_P4C^!RZG^P%JWP^^&?A]OL_A&SL;C3=.A9F,5G9E5906)+;(
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MPLXGG<>ZQ*Y_"OU%\*^._!GC@WZ^#_%-AJG]EWS66H_8+I91;W"@%HGVDX8
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# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>smti-20220404.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa6LObP9z5Z8GekhvWBzbVkKbyQg4IPn0CkE4VsWISIC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:SMTI="http://sanaramedtech.com/20220404" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20220404">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="smti-20220404_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="smti-20220404_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>smti-20220404_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>smti-20220404_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sanaramedtech.com/role/Cover" xlink:href="smti-20220404.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140648679417816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  04,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
    MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200
    Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
    Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20220404.xsd" xlink:type="simple"/>
    <context id="From2022-04-04to2022-04-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2022-04-04</startDate>
            <endDate>2022-04-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-04-04to2022-04-04">0000714256</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-04-04to2022-04-04">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-04-04to2022-04-04">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-04-04to2022-04-04">2022-04-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-04-04to2022-04-04">SANARA     MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-04-04to2022-04-04">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-04-04to2022-04-04">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-04-04to2022-04-04">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-04-04to2022-04-04">1200     Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2022-04-04to2022-04-04">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2022-04-04to2022-04-04">Fort     Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-04-04to2022-04-04">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-04-04to2022-04-04">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-04-04to2022-04-04">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-04-04to2022-04-04">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-04-04to2022-04-04">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-04-04to2022-04-04">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-04-04to2022-04-04">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-04-04to2022-04-04">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-04-04to2022-04-04">Common     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-04-04to2022-04-04">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-04-04to2022-04-04">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-04-04to2022-04-04">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MK1 W'UY\0R"Z)4075?& ("PH;B.^J:/ [=<\2@7"T2LY>N<Y8R&,U"&9J9!
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #[@8A4!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /N!B%1]JA6"
M[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( /N!B%297)PC$ 8  )PG   3              "  <P!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ ^X&(5'>9VZ].!   V!
M !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( /N!B%2?H!OPL0(  .(,   -              "  9$,  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ ^X&(5)>*NQS     $P(   L
M         ( !;0\  %]R96QS+RYR96QS4$L! A0#%     @ ^X&(5*K$(A8S
M 0  (@(   \              ( !5A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( /N!B%0D'INBK0   /@!   :              "  ;81  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /N!B%1ED'F2&0$
M ,\#   3              "  9L2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  .43      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="form8-k.htm">form8-k.htm</File>
    <File>ex10-1.htm</File>
    <File>ex10-2.htm</File>
    <File>ex10-3.htm</File>
    <File>ex99-1.htm</File>
    <File>smti-20220404.xsd</File>
    <File>smti-20220404_lab.xml</File>
    <File>smti-20220404_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "form8-k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20220404_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20220404_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "smti-20220404.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20220404",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-04-04to2022-04-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://sanaramedtech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "form8-k.htm",
      "contextRef": "From2022-04-04to2022-04-04",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001493152-22-009477-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-22-009477-xbrl.zip
M4$L#!!0    ( /N!B%02>U9R<B\  /ZD 0 *    97@Q,"TQ+FAT;>U]:6_;
M2+;V=P/^#W4;\PYL0''B+-TS22: +-$=W;$E7TE.)KBX&)3(DL4.16JX>)E?
M_YZEJEBDY*5['%NRV1\ZED16G=I.G?4Y'S^/CX\^;6]]_.RUN_"OP/\^CGOC
M(^_3QY?\+_SZ4O_\\6#0_29&XV]'WM]^FB9Q_E[LOUKD8AS.52;ZZD(,D[F,
M6_Q%2XQ4&DY_@A?AU9/?^]X'D:O+_(6,PK/XO?!5G*OT@YC+]"R,7^3)XKV
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M650],4\JC%$W0Q1\%#:R$D.,P#]K]!JQ@7Z[MMK+C@.02Y$I0>$K&S3JZ]S
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M: *=;?;]':S8D#^9Y2@WX>\FF%G)#^? !R7+''?_$[)_M+Y9WO1,) @E6DS
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M,@[_+9U EOJ-6;DL*]&O)9J,#((4;T^*PM1!-)EXLW> <33P/OXUV67'<&S
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M=A0B5^-XN?:PANTT;&>#L(]_1=M.;&&RCN7E"@,VF3KB:UV %U[(L%))R"(
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MO@DJB$5G >X-GQ/;G68L,(TY/[3[L=)W^2(7S"MK9,DXNS1"6P5CD>N)6_A
MPB'<>5V=+BYDN()81GAD?(H@"#FM$(ZL,Y>K9_$"E]56^+7'%AMR7^;V5?!]
M\P"$O[&$<\G*;W%R24"K^C8'D3$D REBAMI(1?QM4F304X;8'7F.Q21IXT!C
MR(B1O:Y>>U%9>KWL53)Y>\#K<ZXQJ4=(/.@"UHL$Y$#YG'];P@\@!\\3!AC9
M>;MK:(DM6I[O(U]$KMBCAA(+SBFMB(L#'19 _MO]@QVY2WF@0W5>:$B0;I7;
M-JQN#0=SDP![*\?CS;)R/[*2A+?B96SJ:U,+* 0P/Q07(9"GY4_&M*U7V,;3
M"FQ32P5T)U=X7;.5UG P2UMI24R;*,KT=+?+30)BE76T<,O-@62"5PGC0G%^
MJ(9X5?!M,@]]XI4$/<"8*)8!<JD1JDTQQ:H6\#J,Q;)X38LO8Z8$'7](080L
MV[T24D7@R^0(RZ/K97H=$-^I@B_PPB*1;Y5@R_N[E$X9=ICAK5W88&3,%S*,
ML-EFYZ_A8)9VOHMY'.85O M=J5HQ>[-L3U4 LC1\(.-SW<8(S2;5J-ZI(I7F
MNQ&HOQN FK8KF>:0W=OBR7E9,QF/6Q)=6-.;I@]+]-20NPE<\8(D+ M#C:#Y
MZARD)8,^O<(\L8-R&I8)(KEC<EU[8ZHAYG4WNS0( FVJ07T;>JMHWY5IJC;E
MK N+LC@C<,>I:%J'$;^[[7O/4%_'0(Q?GEOX1274HH[IUH1(/,<[P-;$-DX8
MV-FF9KV&HA>DPF8N)+YE8YI_:B96FKFLW)2M%)NH7D*F<GJ)'3UL'+/55ZA4
MK2EY@.(4\"FNJV9LUW&PDF;0 1?EFVP;OJ7L+0L^%@73O@B[D;0*C4Q5N<OR
M,'*_T$!9Q.=)VB*YK')M!K;6@3/$1DA:P\$L:YJ23%!9&-#.Q74_8IE9E")S
M&/N)EM39*X+PQ>&<))6\K#:C:CC-JN(WK!C-^(18*=Y65?D1VF4%1.:71]LQ
M3S3']'YR.FX#=[V_R/*UQ7G=(!R7^R7Q-$6T.HV8C)&OR 1T[-7.B;8UH"T5
M>-!S2+18TZQ<<CT@'1J>G^2IN+I<:)%G=&L"R^2R/])7=>?T;K..:T36,UZ
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MO&Q"<WB@3.%\+](B,VHCCF=T"OU!XMQC,!7K2Z5R;QNT7-83*Q6.R*IX7N1
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MJT&L"U$9EB-*8WDL==2=(58Y]>''$RGFI$I1[*(LK>E'BMI<5 0(8F#R,:@
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MO+MQ/=^NZWEWXWK>N)[7T(YCU_.I8Z"([[DE Y A"C8!W';BV!5,E3*;;8Y
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MOG!)MTRON)$+^'VL(Z,S9^E$H1LU9M,_F*L[J?:C@@7E%C;B[Z<-& EI8M)
MV;E6+*O.2O-1LDA&<'*(M+6R"BS(>E_FX'8KP[H-'#3*ISA+M&ZP3P38P.UZ
M5^_4<%"3P0E;,DTGM46L\J)<!E5!_SYVH7,\T 'M+G'ZJ#H_Y<L1S15ZW*IH
MBRKY)CJ=6?><[VXX/Z!4FKJ$RV@!K!AXNC8T[+\ C#B^#MA.0^"OJ\#%&4PI
M*=F?1,2C'XNV_+X47)G ,T%OKCLZ#N DE0N>![^EWY/7:""/L/G/M3NPM">2
M/AGT2R-15*Z]&QJ)! F*482BR;D3">9,V^+-+F]YNX?-\I+*6!#0-,4SPJDI
MQ':2COL]8_RZZ%[,L (69YT_7\_/JMA-FS:&.SL&:4?8.PR$?;5 ?C:RX5VI
M5C6D;]?&OK.BK#$S/-6,[$H?^@+N$:9H7R#*B/V-/OR ^HF9''X9S1 :DHY;
M-]&6X484[_B:\2)_N)9T6#]7P'IW#&(1S]0KOJZ/10O._69!#$NG^!=S_.0R
MN1)7EZWD@*GERD\;Q<9!)NP!3%)WC[LHL@;D7HD,D>4D0A0G^N:"%(^U!UL7
MV!L)DA+'"?'\6D[ID&GT>P[7(">9_8'%^&,%8LO<O&YDQ4Z.B3PCF$J+N:$J
MD58F2OS<@10TZS-@J".LJO9<;L1,*6TM2.$$50*A%0@IT$%QDZUP+V?,B7'<
M23#@YRA-Z#F'HP?\FXI36B!UJP, +HMVZDW D$4@-7AI+A\P,&-.*@B3D.6%
M[4"OK-1;1*&!J4F#"21645HG/L)/JB^8/(/A5:"^-!?:0TC*2IF^?/;A6* \
MDU%=,+1GH%21B!2)O9)6*247E3.X=W$T4:C]<!$\MUBY!7+$EG57!-<V7]3.
M1CI8;D!B".K:B4.X4C:;\W,PX]PJ?BL^_; /TG2I)ADE/Y$"BLHDQV@((XN)
ME%*D;'$<.9^E#$]7M?E(E2;T9:DE+,Z"US;<I0R'GN; +,UC%CPOP!(0YH:L
M#KF>:=U3M-_HJA+GK84'97&54I^11FM.<4#5$<$&\:+\V>3T&29XIVKB9,;B
ME1[CZ=J65MC'([D4-HR7H;Z*KJ$4?#5UF90D?C__0E1=+*=*3?$9\1V]3-P6
M:L*&166DVW0RXI!#N$2#;49<WL4W@6%.IZ!DXU6PS\<2P2118,\S[->V2D,4
MHI%\%C=.Z 0UV<:S:0IZ@[IOPI:C':-RS%<_#"QZ.]>1?,)B2&<^4 F<D]/L
M[&& 1(-#+Q8=$.)D3DBW&"3T=)$B[,BF>]UW[UZ';E(Y^8ILH!,#"7]NY*V3
M?_:><P@\2UGRS!V+R4:_G0:(W4.OJ)A%4D]JE]8#WMGJ+>M2WK"E>SA:ES;<
MMGR1;R__P-3;4_9M:]XFMZ=5:=K%=6-3;IJ85I7)Z'->7*+NRD4+!=]-R[N#
M$*9&S;(CN96JP>^[+IQF^S=PP#BG3%@USDF')3K4:D,R"R]G0:\G#J\"MW.R
MW:A,)P'ENU3"E!5(G*+4+9'1G8#5$^XWK9H&/1'T#9FP;KJ.L ;71'*?;"*Y
MMQO)?;*)Y#[02.[??X;WW1'55R8HJ?D P>P":!,!N)LXHB9VK:8:6R'.@,:T
M'2_B**@(9/P+&LMD^ 2]U2FKB35F'L-$)/@Y;_S500_KB_*5B@X+PN]5[P_>
M[Q%..ACA[ $NT)Q*QB 8,?:3\-\+$J>M.< W,Y7B#RRJI!LU4J[+K!C"X2>,
M@([:R87RTBY;+;""0D&;]<]:$VI6F$V?.,V"5CE3UD\0KW\QB9,M3,K1.P+\
M/D6/0I+Q'>SH!Z!OUUA5*2/GLSV8,F0WE;5YZ>%6&^1OR ^6E'78'5CH;,N!
MMK19[JU408X_,66EI;9F=7-4;0L3>*JGHS*J.9,].3^T?FTZQK'M[G>B"*]\
MFI/:R>H[(>QX^KMT')4AI0B9/& X5KMGO Y!R1S%2\B7CC9T"[^5(,:K-Z^I
MVY[IK/#J\9O7$L&0M4J%NUPUV9O:*3LV?DAJ0Y/JMO7D =&/43HP&1+)>%R2
MFV+B/VP]K-O1OD,&:"Z0_R(M$:WUR<X@&B=7E9,TZG3OJ9R=ZNJB80)N <=!
M8T-EPEE-L:1+8SXFK[]G6CC8G1)AHXT^_K%U#(<K9F]SJ^2"%^+[RCHQ$4RL
MC40 I\7"V^9)JEMM.YT/.VE4J(5;D-DR$?$X\>8_@GWG V  6+C1*^N]S8::
MZ5$/ ;V[4B*@F;UK  ,WD6JC4590LR33I\4B-[ !+.Y'8BJQTYA*TPWB,5P]
MFN#EW'KZ;"GM=+:,@<&I+R75LU"W&-T+BG>KBZ6MV(]QP<T,6MOB+TQP+2Q&
MB!U=MY)8-;SNI=+5[4;VA /M9F/X7'%S^%P]%M="MR(W(+XD80).^,RHH6+%
M9\4H;_^UR\T: EF_)6[*RX1:HK7KCX5EY%QDJ*><?L';_[.^_;5!L(VQ$"/+
MNJZEU9+""\=*&Y]6A:RI=77I4V%V'=50 0N7F\HHYS9R0+'#5=/P4,T"Y8XK
M'H]<D<'>"Y1W5\;5T]WRASA<JVOF';;\D6*>, [)F4$>+;F-0?D*^K$X;O)]
M32<C]S-W+IUQ,9L;Y-&':1$VZ'Y,">ZSOD152%^MDL<;3?WKFC!]PUD$L^P@
MZ!SIF)D)?:P3I'2MJ'MZFM?]W336;W&(/=TXQ&[7(?9TXQ#[L1QB*\L$[*S^
M)CQ@:W0WV=PANR:SF"U/+4P>>F+W?>5\!6X*>R!D8GS*I4)09.<1E]\:[^&A
MVPU3=YQQ/(Q)Y)1/1H<7K=+>+O.MW_/+IED-76B/@(-61_:'<9HX#0>]TNE5
M+3O):$?/!FPV^A&LRIE@/YH69IAM0M=:F/@EG.F)12<Y!'H:83_+R#$Q&1$!
MWH#A8-#Q0<,?]'LKNL"(>MB:C.ZJ4J&Q%&W]8KJJ6%./-JDRB+RZ GS)CNE$
M<K:^G46RI6!35OY"; G1O#(*A\J&F1R#A1*(!7EVD:2!=]D#5DO&>!4H+HN-
ME-TD#FT@/T%WFY-5%NNDE%%34H>^=F=!DX5KDH/D^;'V).GC(?NT"NUV*C/W
M#_JANEGO-UVUDW?]@6;$J0VY=V,<?CN+BI9R*'(KWH!%F1[H+D;"TKX47D &
MG<*='*L#Y)" *KZ28]V480E_6M6DJLV>^CUY]6HV<B/NX3^[82,;-O)-;(3Y
MR DZ[,9P99S^?*V;$22_A/5?[:L2, ^J8[K0=T280N" +@B"B>TW]DED256C
MFT^_WKTVIO586@>1$]^=&BY%N)\)$!"0B<D+]AQ4&@T*L?;Q'HQ;*4XQL#EQ
M(HXRA&F2#- L57EET_E+S/>L.+R\NO>[7*>AP@],,W:LL)HJ]AEQ2G0T;JA?
M(49O-0J+)&&%-6'A56V'7+L<2U+FP)C(\N_*AL]-*,L\X!VXUX_0!&6(H[C+
M#]SH*\1/,!&#^$;!#!(]LW0>4\B/%X2R9S13L"MZ/YRDUY#]?E7##"KZ$]]Z
M.!#58!:3"2("299J-,+#SW19$M[F(1Q9+BTR@.8O59ACX!_1AB]^=ZAH6,*G
MUP=E,HWVL=4AV^V=P6L5:>\KF0SSY$\0V/75,G^MY)T[)0M, TUM,B&#J.SO
M,F*_1_=7WN9&9UW@P\(#WHO.,!#+=A'&QZ)AD2?1!(L]<C4%YI>88@>)WFPE
MSJOQ:3\,C,R'D>[R(G^T/YFD6>IT'O1S(^UF5';FF.S*"'^C1)=!VS>^::[P
MWKFO;*N03HD,SZ4K-39>DH1B:Q9,@:,60QA_X#ZE]+'>^,C=]Q>P0X-__._G
M+S'49$O .&XK[(BT)ZE&*FSAF)M*[\%XQ?J^T^KC=OJ"FR#,W"RM='FJ3GCF
M).$@&N5JSB)HN()L94F(D((HP[Y+@4B_R_<1;1DUF&6WTQ+*>XAU5@K;P5H&
M@ZC(7;SR[*H5I/# .I>>3+3%DG&!X9LR)4 TJ_I6[$#A:AJ20YB,5.JJ#?ZK
M3OWJMEAX_!BK@N27^)>:AV5P.KO!W1JG-!XCD_:W571)*,V5#)]Q;A<<$%(N
M:@K<4PNK0OD11@(5VF'$M9<<LP*]790 EZ;X,(.N0)Q^A<)(P-[=,I[:9)M(
M5$UZ'%G"DU98KB:!4?7DHC!:#W$;$ST3D=9]6)0!(N7'(AEMMH6)BL717)53
M+\@7DP2=YQ2D<C[%GD;%91!FH[V%J8R+D>R#;'KGI+@H7=]#*9HSJ>.Z?HZZ
M=HB0'B5E>87,V\V(H:-;7M #TF7]!/HUX;!GFW#8[8;#GFW"83]6..SOK#G?
M)BJ2NILXVB%S]_VRQ)I79.6;L-D]ALWX.,1?=+14(*X2@WX%'%7F<=$9Z"_9
M52<,+J90.?Y@0<35;F1R @BTMVX?X:/&4]TO$Y)VIW#:3:4624F5Y-:-4EGG
MBF^;FR:,$P=&UTO-U#5RF/<EZ Y!2:)M#[:L1E<V)C W1<]RO Z!UVU++"]V
MBZ$/G-QO W\_87!4OQ%?IJEGH C].UQEK!6EP*!(0%:7N;H"^GJ$E?W<Q#(1
M[9,2NI2X?]V][/=R19BI GH:NJ>6>[Y,QU;]ZT#_7%Z-SPT%*(6831N@;$:O
M=DHT*+,[0A.?AO;2[D+3W=EUG!2G?)><UVXZQ+;(-M;9A8&5:2H8]88'K4!U
MM8GK,//=A>Y.F+4/DTQC]3B;RF8H%;/8.^!='/=RKI]ZNO80<Q+10]""*V&K
M?[3P"/3UETX^FKGZG-3D16J*;.4..QZ5TAE/JF<Q;=Q-\.6&0B$?6 )S[C-\
M(:>*TK@I+C\:V&Y!M@F!M YS9CCCMD4SC43!IID/EPRF9YI5*YKHBO\8*TJF
M.9F!^OZV7>*^8SJ2O,N.IL32=M?<*U>,),;>='A?RZ<M!6,=D^)V'(0>%3JL
M@X@?[(0_$7G_$.62,W98^5"4K3Q3I_@$WJV(P.%U0W@S,=>&F0UPNSD7F4\E
MR8)@UI1B*#?#56*;H&^)S"6PV&5&0W$[T;SQ=/T7=J')$>NU=0Q7D;C^J:5F
MS)Y_.OE8,F@->I\+W(?^^Z[VC:'W?I6_WEVDTT :9,RPN-#M5&R+;#E8W9^%
MWK(D:+:29),Y;A'C?. ;_.H-6P/?[UTFWEV.3':\)Q4H,_WK+W(7\$'BB%K;
M?(&C,[I;PBH4+8T;<J&N9,;N$6FL!2]$)X#N8?]!<B_" $[9%WLE.9H)W^ ]
M&)?)9>3Z*FOA3KZDY,X4YC(.E@'V" Q/ &DDT)'$$:R[&!L?.(A@CM=2<,$V
M0OC[QWTF)(4_P$DUBW[O1-\!B?M,M.K6P5@3GRJIXF-YR:+M9Q,@-74@5_5[
M+B"1>T\)DW+WZ5/'R@E0K0R3!09ID#Y-_10'T/WD%6."F3261(0!ZJL3KAMK
METC9))#VK=!M4AU7J@C_:8'O3V"=W;M+Z[JD[E61RJ<@>;QN3[SS%$KR-M_X
MPZU=!T9)S>U24:S@&IP82V);MA9!3<I&)[ZW&.R4[N*^#> 0VE/TED#/R/1[
MFRS@7B R<=F,:IV_ I04=X6W@*^7TR1/_RTW"9@U/^]^DJ%8L@DAS+2I;YA"
M%.>*\T$KD 0U_AX#2-K0I0^MLE/!I<V2T@%IH_O).%:4UN5$?!UK%!@ 7A1I
M>J6</_!;)<B$8]8 $VEQAK2KRW_+Z'.:4UZ,$W+RP[,ZK.4 C6-A?6(!2CM0
MZQP(+<YTA1F,I/'9F$&'&)3O,3&8(5!)W=1^-$TW>#(I@'"9K5=%+PY'UG#0
M%VE9<[*9<V%=G#N-5[9^]_.:D,K/FY#*[894?MZ$5#8AE?742V=+^G&=KP@Z
MNR7T]+7]8#2(ML0#K0WLEJ]3FTF.TU.;>D'V-8JACGJ19DF*N6Y&V=%E2Y?X
M+TF=.N(:_.B$G1/'6AV%)> 0_1[B\3;SN><KLPE0Y >09F0C<N+Z2@)7Q#BB
MN%33M.)N=7ZSVMV]+J1@/@.:6W;U"'1]\@6("X!W "8OXO#*2+OE@JN3TG[\
M2W:;T]8JZ)TTHM[=H4[4Y_O_+_KCZ/S]^^,/R*LW+:COL07U"?MAR,K[C7ON
ML5)_F-@N[3JN@H$;VT?7E!YP)8(%I;G0Y0JF#;&3L"2%\09+@'QKMD:%?$:E
MXNO/ 1\&%*\D,8J<LZEN$EA4]'DQ-_$7/>4)N7KHFSKY8EI+L",R3"E'I%),
MQTILM!NLGY5HVI'M,F+S[CC?_!WC9<>1('[!Z%DQPE*UY N;!O@K,AJ,LQ"V
M'Z&2V4&(.K\X$GS8D1#>4Y+.<)4^5$U'ZT,Y0[]]Q\+D<?($XK#:B)S]8[#V
M..^3/6VT#*XV(@PHDW9HUF5=,./&>$KE:+R9VF1V3AF5@@*354>6GAL90&"I
M4H<'Z-3)L0<3**\&&H9"$P%8,&Y9CHN1S%U8W37QMH-Q1"+.3$<'2)D:4N,L
MZ??T>AXH\[KG[LB&<Z6Y6VC715N(LC=OYHYK?NEIZQQ<<]HQ-\G!/D3L/$8(
MF+BK3$T&Z_?H9G@>_R!Q(G);M"=M'#&X@QP,B9+IM"3,OXYZL*V."C!O'D#]
M[%U4XP%'^2Z+)AO+VG@!>FO<W9!X!]S<=2;M]=&*=DDKTMT3G^X\WX_V_]@_
M/3A[P)K1?3&7<P':%_G(T7NXX'Q7T\I6?FB 3>UVDY**O,C_TAW L <1A]D(
MU#KG#L:Z29%3BS]722YVF)@\_1[1@5<<PI2!$VDC!?+\NL!*.81I'89EDTFZ
MNX?^E!CP  NXY:@?HO1P^5C*$)'X7TF7HAP&U(>TRU$S$5;DDLC.'3<15 ;;
MK<HL48('U&4-WU-QEV=9* C^E3M&KV -P,A_X-OX.J<)F7V9627"FQ972IGF
M43<X&-YU# 5+:$=T(', A,!HNDPY/#JASMI$8DF9I0+!D ["$F?&0P,NOTNP
M:PZ80JO?^Y)](\73=.\)&VH3$"[(L:;F!F\=;=U "4LH=<VFDE'O&DX;\=:-
M[P4;@A4E2WLI]9ZO:H2V!=K3A1OHL'8H$J5Q.N<2!E=$N@?KJ[>HK"/*FP>4
MR\6LEZ3#8_&6K3O2(>LLE3Z2H9X89"UV9>ET]<ZPB\)C)JW8]UO@S*6; 0AV
ML3/PDL5FP5WCTCU9/]E[C7_]EXU__7;]Z[]L_.L/W;^^/DKN'BFY^[\??CR
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M_ +L**\3L +?60/D FR-/XG(E2S$\@ENXV8,L(N 6M21CQ=^ZLIXT@7-H]P
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M<0;!5Z\-Q_4"K"%/3L39E I(+R?/TJEF\Q9D43>XTH;E$[;<12)LPS*2I_*
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MXZU"1&8/W?<1^?3Z!*/QF!'F ^5O0C K5H0MSEN"R@HH:UQD+*:@PP2R;&_
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MI]X?=KY^Z!2'^XVWC?:K?RZZ+U]*E/P_4$L#!!0    ( /N!B%2']SBH/@,
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M,BYH=&U02P$"% ,4    " #[@8A47<]<_FQ4   0$@( "@
M@ $Z7P  97@Q,"TS+FAT;5!+ 0(4 Q0    ( /N!B%0CH9B ?PH  %@J   *
M              "  <ZS  !E>#DY+3$N:'1M4$L! A0#%     @ ^X&(5-S
ME,=*)0  -B8!  L              ( !=;X  &9O<FTX+6LN:'1M4$L! A0#
M%     @ ^X&(5(?W.*@^ P  ! P  !$              ( !Z.,  '-M=&DM
M,C R,C T,#0N>'-D4$L! A0#%     @ ^X&(5#QB>.[_"@  ;(<  !4
M         ( !5><  '-M=&DM,C R,C T,#1?;&%B+GAM;%!+ 0(4 Q0    (
M /N!B%3$HZR<6 <  ,M8   5              "  8?R  !S;71I+3(P,C(P
A-# T7W!R92YX;6Q02P4&      @ " #> 0  $OH

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
